BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1082086 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2COCC(C1)N2C(=O)c1cccc(OC(F)F)n1 InChI=1S/C29H30F2N6O3/c1-18(2)19-7-9-20(10-8-19)26-24(36-12-4-11-32-29(36)34-26)15-35-13-21-16-39-17-22(14-35)37(21)27(38)23-5-3-6-25(33-23)40-28(30)31/h3-12,18,21-22,28H,13-17H2,1-2H3 IQJPMLROUYSIIJ-UHFFFAOYSA-N 515508 US11098063, Example 19::[6-(Difluoromethoxy)pyridin-2-yl](7-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)methanone Potassium channel subfamily K member 3 Human 239 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515508&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 150593590 461601615 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082087 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2COCC(C1)N2C(=O)c1cccc(OC(F)F)n1 InChI=1S/C29H30F2N6O3/c1-18(2)19-7-9-20(10-8-19)26-24(36-12-4-11-32-29(36)34-26)15-35-13-21-16-39-17-22(14-35)37(21)27(38)23-5-3-6-25(33-23)40-28(30)31/h3-12,18,21-22,28H,13-17H2,1-2H3 IQJPMLROUYSIIJ-UHFFFAOYSA-N 515508 US11098063, Example 19::[6-(Difluoromethoxy)pyridin-2-yl](7-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)methanone Potassium channel subfamily K member 9 Homo sapiens 774 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515508&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 150593590 461601615 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082088 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H24Cl2N6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-18-7-8-19(34)14-32(13-18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 GWCXCQVXKXFHMH-UHFFFAOYSA-N 515509 (3-Chloro-6-methoxypyridin-2-yl)(3-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)methanone::US11098063, Example 21 Potassium channel subfamily K member 3 Human 19.2 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515509&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146463212 461601616 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082089 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H24Cl2N6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-18-7-8-19(34)14-32(13-18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 GWCXCQVXKXFHMH-UHFFFAOYSA-N 515509 (3-Chloro-6-methoxypyridin-2-yl)(3-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)methanone::US11098063, Example 21 Potassium channel subfamily K member 9 Homo sapiens 32.9 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515509&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146463212 461601616 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082090 COc1ccc(Cl)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C29H31ClN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-22-10-9-21(34)16-36(22)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 DUJLETLIURKNQV-UHFFFAOYSA-N 515510 (3-Chloro-6-methoxypyridin-2-yl)(5-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 2)::US11098063, Example 26::US11098063, Example 69 Potassium channel subfamily K member 3 Human 31.2 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515510&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462923 461601617 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082091 COc1ccc(Cl)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C29H31ClN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-22-10-9-21(34)16-36(22)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 DUJLETLIURKNQV-UHFFFAOYSA-N 515510 (3-Chloro-6-methoxypyridin-2-yl)(5-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 2)::US11098063, Example 26::US11098063, Example 69 Potassium channel subfamily K member 9 Homo sapiens 140 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515510&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462923 461601617 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082092 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CN2C(=O)c1ncoc1C1CC1 InChI=1S/C29H32N6O2/c1-18(2)19-4-6-20(7-5-19)25-24(34-13-3-12-30-29(34)32-25)16-33-14-23-11-10-22(33)15-35(23)28(36)26-27(21-8-9-21)37-17-31-26/h3-7,12-13,17-18,21-23H,8-11,14-16H2,1-2H3 JUFGAQSEOJOLNF-UHFFFAOYSA-N 515511 (5-Cyclopropyl-1,3-oxazol-4-yl)(5-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 2)::US11098063, Example 27::US11098063, Example 70 Potassium channel subfamily K member 3 Human 17.9 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515511&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462916 461601618 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082093 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CN2C(=O)c1ncoc1C1CC1 InChI=1S/C29H32N6O2/c1-18(2)19-4-6-20(7-5-19)25-24(34-13-3-12-30-29(34)32-25)16-33-14-23-11-10-22(33)15-35(23)28(36)26-27(21-8-9-21)37-17-31-26/h3-7,12-13,17-18,21-23H,8-11,14-16H2,1-2H3 JUFGAQSEOJOLNF-UHFFFAOYSA-N 515511 (5-Cyclopropyl-1,3-oxazol-4-yl)(5-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 2)::US11098063, Example 27::US11098063, Example 70 Potassium channel subfamily K member 9 Homo sapiens 367 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515511&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462916 461601618 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082094 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H31FN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-21-9-10-22(16-34)36(21)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 OGGHXOJOVOYBOH-UHFFFAOYSA-N 515512 (3-Fluoro-6-methoxypyridin-2-yl)(3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)methanone::US11098063, Example 28 Potassium channel subfamily K member 3 Human 20.5 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515512 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515512&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462796 461601619 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082095 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H31FN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-21-9-10-22(16-34)36(21)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 OGGHXOJOVOYBOH-UHFFFAOYSA-N 515512 (3-Fluoro-6-methoxypyridin-2-yl)(3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)methanone::US11098063, Example 28 Potassium channel subfamily K member 9 Homo sapiens 6.60 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515512 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515512&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462796 461601619 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082096 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H31ClN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-21-9-10-22(16-34)36(21)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 VDKJCAWGDJJKNL-UHFFFAOYSA-N 515513 (3-Chloro-6-methoxypyridin-2-yl)(3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)methanone::US11098063, Example 29 Potassium channel subfamily K member 3 Human 21.0 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515513&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462757 461601620 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082097 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H31ClN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-21-9-10-22(16-34)36(21)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 VDKJCAWGDJJKNL-UHFFFAOYSA-N 515513 (3-Chloro-6-methoxypyridin-2-yl)(3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)methanone::US11098063, Example 29 Potassium channel subfamily K member 9 Homo sapiens 42.7 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515513&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462757 461601620 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082098 COc1ccc(F)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H24ClFN6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-14-18-7-8-19(34)13-32(18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 LLVGWHFNQXAKJW-UHFFFAOYSA-N 515514 US11098063, Example 24::US11098063, Example 41 Potassium channel subfamily K member 3 Human 44.4 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515514&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462905 461601621 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082099 COc1ccc(F)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H24ClFN6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-14-18-7-8-19(34)13-32(18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 LLVGWHFNQXAKJW-UHFFFAOYSA-N 515514 US11098063, Example 24::US11098063, Example 41 Potassium channel subfamily K member 9 Homo sapiens 71.8 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515514&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462905 461601621 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082100 CCc1ocnc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C25H25ClN6O2/c1-2-21-23(28-15-34-21)24(33)32-18-8-9-19(32)13-30(12-18)14-20-22(16-4-6-17(26)7-5-16)29-25-27-10-3-11-31(20)25/h3-7,10-11,15,18-19H,2,8-9,12-14H2,1H3 UVWUDBXLAOOGPT-UHFFFAOYSA-N 515515 US11098063, Example 51 Potassium channel subfamily K member 3 Human 21.7 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515515 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515515&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475149 461601622 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082101 CCc1ocnc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C25H25ClN6O2/c1-2-21-23(28-15-34-21)24(33)32-18-8-9-19(32)13-30(12-18)14-20-22(16-4-6-17(26)7-5-16)29-25-27-10-3-11-31(20)25/h3-7,10-11,15,18-19H,2,8-9,12-14H2,1H3 UVWUDBXLAOOGPT-UHFFFAOYSA-N 515515 US11098063, Example 51 Potassium channel subfamily K member 9 Homo sapiens 35.9 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515515 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515515&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475149 461601622 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082102 CC(C)(C)OC(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H28ClN5O3/c1-24(2,3)33-23(31)30-18-11-28(12-19(30)15-32-14-18)13-20-21(16-5-7-17(25)8-6-16)27-22-26-9-4-10-29(20)22/h4-10,18-19H,11-15H2,1-3H3 OSTHKKUVVOYEMZ-UHFFFAOYSA-N 515516 US11098063, Example 1::tert-Butyl 7-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]nonane-9-carboxylate Potassium channel subfamily K member 3 Human 1700 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515516 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515516&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146463902 461601623 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082103 CC(C)(C)OC(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H28ClN5O3/c1-24(2,3)33-23(31)30-18-11-28(12-19(30)15-32-14-18)13-20-21(16-5-7-17(25)8-6-16)27-22-26-9-4-10-29(20)22/h4-10,18-19H,11-15H2,1-3H3 OSTHKKUVVOYEMZ-UHFFFAOYSA-N 515516 US11098063, Example 1::tert-Butyl 7-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]nonane-9-carboxylate Potassium channel subfamily K member 9 Homo sapiens 400 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515516 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515516&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146463902 461601623 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082104 CC(C)(C)OC(=O)N1C[C@H]2CC[C@@H]1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C24H28ClN5O2/c1-24(2,3)32-23(31)30-14-18-9-10-19(30)13-28(18)15-20-21(16-5-7-17(25)8-6-16)27-22-26-11-4-12-29(20)22/h4-8,11-12,18-19H,9-10,13-15H2,1-3H3/t18-,19-/m1/s1 AIOULOBZHPNORY-RTBURBONSA-N 515517 US11098063, Example 4::tert-Butyl 5-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]octane-2-carboxylate (Enantiomers 1 and 2) Potassium channel subfamily K member 3 Human 470 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515517&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 162678174 461601624 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082105 CC(C)(C)OC(=O)N1C[C@H]2CC[C@@H]1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C24H28ClN5O2/c1-24(2,3)32-23(31)30-14-18-9-10-19(30)13-28(18)15-20-21(16-5-7-17(25)8-6-16)27-22-26-11-4-12-29(20)22/h4-8,11-12,18-19H,9-10,13-15H2,1-3H3/t18-,19-/m1/s1 AIOULOBZHPNORY-RTBURBONSA-N 515517 US11098063, Example 4::tert-Butyl 5-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]octane-2-carboxylate (Enantiomers 1 and 2) Potassium channel subfamily K member 9 Homo sapiens 97.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515517&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 162678174 461601624 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082106 CC(C)(C)OC(=O)N1C[C@@H]2CC[C@@H]1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C24H28ClN5O2/c1-24(2,3)32-23(31)30-14-18-9-10-19(30)13-28(18)15-20-21(16-5-7-17(25)8-6-16)27-22-26-11-4-12-29(20)22/h4-8,11-12,18-19H,9-10,13-15H2,1-3H3/t18-,19+/m0/s1 AIOULOBZHPNORY-RBUKOAKNSA-N 515631 US11098063, Example 5::tert-Butyl 5-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]octane-2-carboxylate (Enantiomers 1 and 2) Potassium channel subfamily K member 3 Human 17000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515631 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515631&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 162678176 461601727 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082107 CC(C)(C)OC(=O)N1C[C@@H]2CC[C@@H]1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C24H28ClN5O2/c1-24(2,3)32-23(31)30-14-18-9-10-19(30)13-28(18)15-20-21(16-5-7-17(25)8-6-16)27-22-26-11-4-12-29(20)22/h4-8,11-12,18-19H,9-10,13-15H2,1-3H3/t18-,19+/m0/s1 AIOULOBZHPNORY-RBUKOAKNSA-N 515631 US11098063, Example 5::tert-Butyl 5-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]octane-2-carboxylate (Enantiomers 1 and 2) Potassium channel subfamily K member 9 Homo sapiens 1300 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515631 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515631&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 162678176 461601727 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082108 CC(C)(C)OC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H28ClN5O2/c1-24(2,3)32-23(31)30-18-9-10-19(30)14-28(13-18)15-20-21(16-5-7-17(25)8-6-16)27-22-26-11-4-12-29(20)22/h4-8,11-12,18-19H,9-10,13-15H2,1-3H3 HIXAUKLVHCOQTN-UHFFFAOYSA-N 515518 US11098063, Example 6::tert-Butyl 3-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]octane-8-carboxylate Potassium channel subfamily K member 3 Human 1400 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515518 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515518&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462943 461601625 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082109 CC(C)(C)OC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H28ClN5O2/c1-24(2,3)32-23(31)30-18-9-10-19(30)14-28(13-18)15-20-21(16-5-7-17(25)8-6-16)27-22-26-11-4-12-29(20)22/h4-8,11-12,18-19H,9-10,13-15H2,1-3H3 HIXAUKLVHCOQTN-UHFFFAOYSA-N 515518 US11098063, Example 6::tert-Butyl 3-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]octane-8-carboxylate Potassium channel subfamily K member 9 Homo sapiens 41.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515518 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515518&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462943 461601625 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082110 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CN2C(=O)OC(C)(C)C InChI=1S/C27H35N5O2/c1-18(2)19-7-9-20(10-8-19)24-23(31-14-6-13-28-25(31)29-24)17-30-15-22-12-11-21(30)16-32(22)26(33)34-27(3,4)5/h6-10,13-14,18,21-22H,11-12,15-17H2,1-5H3 ZCDJIDOPTNDVAQ-UHFFFAOYSA-N 515519 US11098063, Example 7::tert-Butyl 5-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidine-3-yl]methyl}-2,5-diazabicyclo[2.2.2]octane-2-carboxylate (Racemate) Potassium channel subfamily K member 3 Human 8600 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515519 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515519&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462900 461601626 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082111 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CN2C(=O)OC(C)(C)C InChI=1S/C27H35N5O2/c1-18(2)19-7-9-20(10-8-19)24-23(31-14-6-13-28-25(31)29-24)17-30-15-22-12-11-21(30)16-32(22)26(33)34-27(3,4)5/h6-10,13-14,18,21-22H,11-12,15-17H2,1-5H3 ZCDJIDOPTNDVAQ-UHFFFAOYSA-N 515519 US11098063, Example 7::tert-Butyl 5-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidine-3-yl]methyl}-2,5-diazabicyclo[2.2.2]octane-2-carboxylate (Racemate) Potassium channel subfamily K member 9 Homo sapiens 570 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515519 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515519&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462900 461601626 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082112 CC(N1CC2CCC(C1)N2C(=O)OC(C)(C)C)c1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C25H30ClN5O2/c1-16(29-14-19-10-11-20(15-29)31(19)24(32)33-25(2,3)4)22-21(17-6-8-18(26)9-7-17)28-23-27-12-5-13-30(22)23/h5-9,12-13,16,19-20H,10-11,14-15H2,1-4H3 BRQUOSSZQFFDTO-UHFFFAOYSA-N 515520 US11098063, Example 10::tert-Butyl 3-{1-[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]ethyl}-3,8-diazabicyclo[3.2.1]octane-8-carboxylate (Racemate) Potassium channel subfamily K member 3 Human 2200 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515520 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515520&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462911 461601627 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082113 CC(N1CC2CCC(C1)N2C(=O)OC(C)(C)C)c1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C25H30ClN5O2/c1-16(29-14-19-10-11-20(15-29)31(19)24(32)33-25(2,3)4)22-21(17-6-8-18(26)9-7-17)28-23-27-12-5-13-30(22)23/h5-9,12-13,16,19-20H,10-11,14-15H2,1-4H3 BRQUOSSZQFFDTO-UHFFFAOYSA-N 515520 US11098063, Example 10::tert-Butyl 3-{1-[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]ethyl}-3,8-diazabicyclo[3.2.1]octane-8-carboxylate (Racemate) Potassium channel subfamily K member 9 Homo sapiens 130 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515520 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515520&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462911 461601627 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082114 CC(C)(C)OC(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Br)cc1 InChI=1S/C24H28BrN5O2/c1-24(2,3)32-23(31)30-14-18-9-10-19(30)13-28(18)15-20-21(16-5-7-17(25)8-6-16)27-22-26-11-4-12-29(20)22/h4-8,11-12,18-19H,9-10,13-15H2,1-3H3 LSGZHFKQDXJNFX-UHFFFAOYSA-N 515521 US11098063, Example 11 Potassium channel subfamily K member 3 Human 2500 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515521 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515521&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475154 461601628 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082115 CC(C)(C)OC(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Br)cc1 InChI=1S/C24H28BrN5O2/c1-24(2,3)32-23(31)30-14-18-9-10-19(30)13-28(18)15-20-21(16-5-7-17(25)8-6-16)27-22-26-11-4-12-29(20)22/h4-8,11-12,18-19H,9-10,13-15H2,1-3H3 LSGZHFKQDXJNFX-UHFFFAOYSA-N 515521 US11098063, Example 11 Potassium channel subfamily K member 9 Homo sapiens 16.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515521 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515521&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475154 461601628 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082116 CC(C)(C)OC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Br)cc1)C2 InChI=1S/C24H28BrN5O2/c1-24(2,3)32-23(31)30-18-9-10-19(30)14-28(13-18)15-20-21(16-5-7-17(25)8-6-16)27-22-26-11-4-12-29(20)22/h4-8,11-12,18-19H,9-10,13-15H2,1-3H3 VPDMXQRQZVDONU-UHFFFAOYSA-N 515522 US11098063, Example 12 Potassium channel subfamily K member 3 Human 220 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515522 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515522&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462851 461601629 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082117 CC(C)(C)OC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Br)cc1)C2 InChI=1S/C24H28BrN5O2/c1-24(2,3)32-23(31)30-18-9-10-19(30)14-28(13-18)15-20-21(16-5-7-17(25)8-6-16)27-22-26-11-4-12-29(20)22/h4-8,11-12,18-19H,9-10,13-15H2,1-3H3 VPDMXQRQZVDONU-UHFFFAOYSA-N 515522 US11098063, Example 12 Potassium channel subfamily K member 9 Homo sapiens 13.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515522 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515522&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462851 461601629 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082118 COc1cccc(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H25ClN6O3/c1-35-23-5-2-4-21(29-23)25(34)33-19-12-31(13-20(33)16-36-15-19)14-22-24(17-6-8-18(27)9-7-17)30-26-28-10-3-11-32(22)26/h2-11,19-20H,12-16H2,1H3 PNRHBIXNPFBEKL-UHFFFAOYSA-N 515523 (7-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)(6-methoxypyridin-2-yl)methanone::US11098063, Example 13 Potassium channel subfamily K member 3 Human 1500 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515523 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515523&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462827 461601630 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082119 COc1cccc(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H25ClN6O3/c1-35-23-5-2-4-21(29-23)25(34)33-19-12-31(13-20(33)16-36-15-19)14-22-24(17-6-8-18(27)9-7-17)30-26-28-10-3-11-32(22)26/h2-11,19-20H,12-16H2,1H3 PNRHBIXNPFBEKL-UHFFFAOYSA-N 515523 (7-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)(6-methoxypyridin-2-yl)methanone::US11098063, Example 13 Potassium channel subfamily K member 9 Homo sapiens 33.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515523 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515523&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462827 461601630 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082120 COc1ccc(Cl)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H24Cl2N6O3/c1-36-22-8-7-20(28)24(30-22)25(35)34-18-11-32(12-19(34)15-37-14-18)13-21-23(16-3-5-17(27)6-4-16)31-26-29-9-2-10-33(21)26/h2-10,18-19H,11-15H2,1H3 CVFYGSDKHZIPAR-UHFFFAOYSA-N 515524 (3-Chloro-6-methoxypyridin-2-yl)(7-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)methanone::US11098063, Example 14 Potassium channel subfamily K member 3 Human 7600 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515524 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515524&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462695 461601631 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082121 COc1ccc(Cl)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H24Cl2N6O3/c1-36-22-8-7-20(28)24(30-22)25(35)34-18-11-32(12-19(34)15-37-14-18)13-21-23(16-3-5-17(27)6-4-16)31-26-29-9-2-10-33(21)26/h2-10,18-19H,11-15H2,1H3 CVFYGSDKHZIPAR-UHFFFAOYSA-N 515524 (3-Chloro-6-methoxypyridin-2-yl)(7-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)methanone::US11098063, Example 14 Potassium channel subfamily K member 9 Homo sapiens 170 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515524 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515524&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462695 461601631 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082122 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H24ClFN6O3/c1-36-22-8-7-20(28)24(30-22)25(35)34-18-11-32(12-19(34)15-37-14-18)13-21-23(16-3-5-17(27)6-4-16)31-26-29-9-2-10-33(21)26/h2-10,18-19H,11-15H2,1H3 IDQHHCOWPCFYIN-UHFFFAOYSA-N 515525 (7-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)(3-fluoro-6-methoxypyridin-2-yl)methanone::US11098063, Example 15 Potassium channel subfamily K member 3 Human 1100 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515525 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515525&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462988 461601632 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082123 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H24ClFN6O3/c1-36-22-8-7-20(28)24(30-22)25(35)34-18-11-32(12-19(34)15-37-14-18)13-21-23(16-3-5-17(27)6-4-16)31-26-29-9-2-10-33(21)26/h2-10,18-19H,11-15H2,1H3 IDQHHCOWPCFYIN-UHFFFAOYSA-N 515525 (7-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)(3-fluoro-6-methoxypyridin-2-yl)methanone::US11098063, Example 15 Potassium channel subfamily K member 9 Homo sapiens 19.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515525 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515525&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462988 461601632 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082124 CSc1cccc(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H25ClN6O2S/c1-36-23-5-2-4-21(29-23)25(34)33-19-12-31(13-20(33)16-35-15-19)14-22-24(17-6-8-18(27)9-7-17)30-26-28-10-3-11-32(22)26/h2-11,19-20H,12-16H2,1H3 PUSPHEWNSUMZGD-UHFFFAOYSA-N 515526 (7-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)[6-(methylsulfanyl)pyridin-2-yl]methanone::US11098063, Example 16 Potassium channel subfamily K member 3 Human 670 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515526 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515526&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462957 461601633 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082125 CSc1cccc(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H25ClN6O2S/c1-36-23-5-2-4-21(29-23)25(34)33-19-12-31(13-20(33)16-35-15-19)14-22-24(17-6-8-18(27)9-7-17)30-26-28-10-3-11-32(22)26/h2-11,19-20H,12-16H2,1H3 PUSPHEWNSUMZGD-UHFFFAOYSA-N 515526 (7-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)[6-(methylsulfanyl)pyridin-2-yl]methanone::US11098063, Example 16 Potassium channel subfamily K member 9 Homo sapiens 12.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515526 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515526&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462957 461601633 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082126 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2COCC(C1)N2C(=O)C1CCCC1 InChI=1S/C25H28ClN5O2/c26-19-8-6-17(7-9-19)23-22(30-11-3-10-27-25(30)28-23)14-29-12-20-15-33-16-21(13-29)31(20)24(32)18-4-1-2-5-18/h3,6-11,18,20-21H,1-2,4-5,12-16H2 LGQSRUQVMSVYOT-UHFFFAOYSA-N 515527 (7-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)(cyclopentyl)methanone::US11098063, Example 17 Potassium channel subfamily K member 3 Human 1200 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515527 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515527&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462937 461601634 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082127 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2COCC(C1)N2C(=O)C1CCCC1 InChI=1S/C25H28ClN5O2/c26-19-8-6-17(7-9-19)23-22(30-11-3-10-27-25(30)28-23)14-29-12-20-15-33-16-21(13-29)31(20)24(32)18-4-1-2-5-18/h3,6-11,18,20-21H,1-2,4-5,12-16H2 LGQSRUQVMSVYOT-UHFFFAOYSA-N 515527 (7-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)(cyclopentyl)methanone::US11098063, Example 17 Potassium channel subfamily K member 9 Homo sapiens 33.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515527 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515527&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462937 461601634 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082128 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H31FN6O3/c1-18(2)19-5-7-20(8-6-19)26-24(35-12-4-11-31-29(35)33-26)15-34-13-21-16-39-17-22(14-34)36(21)28(37)27-23(30)9-10-25(32-27)38-3/h4-12,18,21-22H,13-17H2,1-3H3 PQXWBPGBEAUOBT-UHFFFAOYSA-N 515528 (3-Fluoro-6-methoxypyridin-2-yl)(7-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)methanone::US11098063, Example 18 Potassium channel subfamily K member 3 Human 910 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515528&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462924 461601635 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082129 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H31FN6O3/c1-18(2)19-5-7-20(8-6-19)26-24(35-12-4-11-31-29(35)33-26)15-34-13-21-16-39-17-22(14-34)36(21)28(37)27-23(30)9-10-25(32-27)38-3/h4-12,18,21-22H,13-17H2,1-3H3 PQXWBPGBEAUOBT-UHFFFAOYSA-N 515528 (3-Fluoro-6-methoxypyridin-2-yl)(7-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)methanone::US11098063, Example 18 Potassium channel subfamily K member 9 Homo sapiens 8.60 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515528&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462924 461601635 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082130 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2COCC(C1)N2C(=O)c1cccc(OC(F)F)n1 InChI=1S/C29H30F2N6O3/c1-18(2)19-7-9-20(10-8-19)26-24(36-12-4-11-32-29(36)34-26)15-35-13-21-16-39-17-22(14-35)37(21)27(38)23-5-3-6-25(33-23)40-28(30)31/h3-12,18,21-22,28H,13-17H2,1-2H3 IQJPMLROUYSIIJ-UHFFFAOYSA-N 515508 US11098063, Example 19::[6-(Difluoromethoxy)pyridin-2-yl](7-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)methanone Potassium channel subfamily K member 3 Human 22000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515508&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 150593590 461601615 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082131 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2COCC(C1)N2C(=O)c1cccc(OC(F)F)n1 InChI=1S/C29H30F2N6O3/c1-18(2)19-7-9-20(10-8-19)26-24(36-12-4-11-32-29(36)34-26)15-35-13-21-16-39-17-22(14-35)37(21)27(38)23-5-3-6-25(33-23)40-28(30)31/h3-12,18,21-22,28H,13-17H2,1-2H3 IQJPMLROUYSIIJ-UHFFFAOYSA-N 515508 US11098063, Example 19::[6-(Difluoromethoxy)pyridin-2-yl](7-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3-oxa-7,9-diazabicyclo[3.3.1]non-9-yl)methanone Potassium channel subfamily K member 9 Homo sapiens 59.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515508&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 150593590 461601615 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082132 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H25ClN6O2/c1-35-23-5-2-4-21(29-23)25(34)33-19-10-11-20(33)15-31(14-19)16-22-24(17-6-8-18(27)9-7-17)30-26-28-12-3-13-32(22)26/h2-9,12-13,19-20H,10-11,14-16H2,1H3 YJADTYIFXPYAMV-UHFFFAOYSA-N 515529 (3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)(6-methoxypyridin-2-yl)methanone::US11098063, Example 20 Potassium channel subfamily K member 3 Human 160 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515529&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462747 461601636 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082133 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H25ClN6O2/c1-35-23-5-2-4-21(29-23)25(34)33-19-10-11-20(33)15-31(14-19)16-22-24(17-6-8-18(27)9-7-17)30-26-28-12-3-13-32(22)26/h2-9,12-13,19-20H,10-11,14-16H2,1H3 YJADTYIFXPYAMV-UHFFFAOYSA-N 515529 (3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)(6-methoxypyridin-2-yl)methanone::US11098063, Example 20 Potassium channel subfamily K member 9 Homo sapiens 38.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515529&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462747 461601636 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082134 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H24Cl2N6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-18-7-8-19(34)14-32(13-18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 GWCXCQVXKXFHMH-UHFFFAOYSA-N 515509 (3-Chloro-6-methoxypyridin-2-yl)(3-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)methanone::US11098063, Example 21 Potassium channel subfamily K member 3 Human 140 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515509&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146463212 461601616 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082135 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H24Cl2N6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-18-7-8-19(34)14-32(13-18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 GWCXCQVXKXFHMH-UHFFFAOYSA-N 515509 (3-Chloro-6-methoxypyridin-2-yl)(3-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)methanone::US11098063, Example 21 Potassium channel subfamily K member 9 Homo sapiens 4.20 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515509&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146463212 461601616 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082136 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H24ClFN6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-18-7-8-19(34)14-32(13-18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 SMVLTESEHRAPDU-UHFFFAOYSA-N 515530 (3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)(3-fluoro-6-methoxypyridin-2-yl)methanone::US11098063, Example 22 Potassium channel subfamily K member 3 Human 340 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515530 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515530&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462748 461601637 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082137 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H24ClFN6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-18-7-8-19(34)14-32(13-18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 SMVLTESEHRAPDU-UHFFFAOYSA-N 515530 (3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)(3-fluoro-6-methoxypyridin-2-yl)methanone::US11098063, Example 22 Potassium channel subfamily K member 9 Homo sapiens 5.20 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515530 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515530&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462748 461601637 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082138 COc1ccc(Cl)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H24Cl2N6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-14-18-7-8-19(34)13-32(18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 DAKTUVDDMZBJNU-UHFFFAOYSA-N 515531 (3-Chloro-6-methoxypyridin-2-yl)(5-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 1)::US11098063, Example 23::US11098063, Example 45 Potassium channel subfamily K member 3 Human 1600 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515531 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515531&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462654 461601638 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082139 COc1ccc(Cl)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H24Cl2N6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-14-18-7-8-19(34)13-32(18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 DAKTUVDDMZBJNU-UHFFFAOYSA-N 515531 (3-Chloro-6-methoxypyridin-2-yl)(5-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 1)::US11098063, Example 23::US11098063, Example 45 Potassium channel subfamily K member 9 Homo sapiens 100.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515531 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515531&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462654 461601638 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082140 COc1ccc(F)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H24ClFN6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-14-18-7-8-19(34)13-32(18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 LLVGWHFNQXAKJW-UHFFFAOYSA-N 515514 US11098063, Example 24::US11098063, Example 41 Potassium channel subfamily K member 3 Human 410 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515514&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462905 461601621 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082141 COc1ccc(F)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H24ClFN6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-14-18-7-8-19(34)13-32(18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 LLVGWHFNQXAKJW-UHFFFAOYSA-N 515514 US11098063, Example 24::US11098063, Example 41 Potassium channel subfamily K member 9 Homo sapiens 102 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515514&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462905 461601621 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082142 COc1ccc(C)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H27ClN6O2/c1-17-4-11-23(36-2)30-24(17)26(35)34-15-20-9-10-21(34)14-32(20)16-22-25(18-5-7-19(28)8-6-18)31-27-29-12-3-13-33(22)27/h3-8,11-13,20-21H,9-10,14-16H2,1-2H3 KTKUCZRYJQWFBF-UHFFFAOYSA-N 515533 (5-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)(6-methoxy-3-methylpyridin-2-yl)methanone (Enantiomer 1)::US11098063, Example 25 Potassium channel subfamily K member 3 Human 1100 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515533 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515533&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462960 461601639 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082143 COc1ccc(C)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H27ClN6O2/c1-17-4-11-23(36-2)30-24(17)26(35)34-15-20-9-10-21(34)14-32(20)16-22-25(18-5-7-19(28)8-6-18)31-27-29-12-3-13-33(22)27/h3-8,11-13,20-21H,9-10,14-16H2,1-2H3 KTKUCZRYJQWFBF-UHFFFAOYSA-N 515533 (5-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)(6-methoxy-3-methylpyridin-2-yl)methanone (Enantiomer 1)::US11098063, Example 25 Potassium channel subfamily K member 9 Homo sapiens 71.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515533 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515533&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462960 461601639 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082144 COc1ccc(Cl)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C29H31ClN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-22-10-9-21(34)16-36(22)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 DUJLETLIURKNQV-UHFFFAOYSA-N 515510 (3-Chloro-6-methoxypyridin-2-yl)(5-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 2)::US11098063, Example 26::US11098063, Example 69 Potassium channel subfamily K member 3 Human 1400 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515510&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462923 461601617 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082145 COc1ccc(Cl)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C29H31ClN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-22-10-9-21(34)16-36(22)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 DUJLETLIURKNQV-UHFFFAOYSA-N 515510 (3-Chloro-6-methoxypyridin-2-yl)(5-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 2)::US11098063, Example 26::US11098063, Example 69 Potassium channel subfamily K member 9 Homo sapiens 16.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515510&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462923 461601617 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082146 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CN2C(=O)c1ncoc1C1CC1 InChI=1S/C29H32N6O2/c1-18(2)19-4-6-20(7-5-19)25-24(34-13-3-12-30-29(34)32-25)16-33-14-23-11-10-22(33)15-35(23)28(36)26-27(21-8-9-21)37-17-31-26/h3-7,12-13,17-18,21-23H,8-11,14-16H2,1-2H3 JUFGAQSEOJOLNF-UHFFFAOYSA-N 515511 (5-Cyclopropyl-1,3-oxazol-4-yl)(5-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 2)::US11098063, Example 27::US11098063, Example 70 Potassium channel subfamily K member 3 Human 1200 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515511&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462916 461601618 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082147 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CN2C(=O)c1ncoc1C1CC1 InChI=1S/C29H32N6O2/c1-18(2)19-4-6-20(7-5-19)25-24(34-13-3-12-30-29(34)32-25)16-33-14-23-11-10-22(33)15-35(23)28(36)26-27(21-8-9-21)37-17-31-26/h3-7,12-13,17-18,21-23H,8-11,14-16H2,1-2H3 JUFGAQSEOJOLNF-UHFFFAOYSA-N 515511 (5-Cyclopropyl-1,3-oxazol-4-yl)(5-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 2)::US11098063, Example 27::US11098063, Example 70 Potassium channel subfamily K member 9 Homo sapiens 10.00 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515511&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462916 461601618 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082148 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H31FN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-21-9-10-22(16-34)36(21)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 OGGHXOJOVOYBOH-UHFFFAOYSA-N 515512 (3-Fluoro-6-methoxypyridin-2-yl)(3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)methanone::US11098063, Example 28 Potassium channel subfamily K member 3 Human 290 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515512 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515512&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462796 461601619 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082149 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H31FN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-21-9-10-22(16-34)36(21)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 OGGHXOJOVOYBOH-UHFFFAOYSA-N 515512 (3-Fluoro-6-methoxypyridin-2-yl)(3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)methanone::US11098063, Example 28 Potassium channel subfamily K member 9 Homo sapiens 3.20 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515512 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515512&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462796 461601619 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082150 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H31ClN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-21-9-10-22(16-34)36(21)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 VDKJCAWGDJJKNL-UHFFFAOYSA-N 515513 (3-Chloro-6-methoxypyridin-2-yl)(3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)methanone::US11098063, Example 29 Potassium channel subfamily K member 3 Human 280 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515513&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462757 461601620 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082151 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H31ClN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-21-9-10-22(16-34)36(21)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 VDKJCAWGDJJKNL-UHFFFAOYSA-N 515513 (3-Chloro-6-methoxypyridin-2-yl)(3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)methanone::US11098063, Example 29 Potassium channel subfamily K member 9 Homo sapiens 1.80 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515513&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462757 461601620 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082152 Fc1ccccc1C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H23ClFN5O2/c27-18-8-6-17(7-9-18)24-23(32-11-3-10-29-26(32)30-24)14-31-12-19-15-35-16-20(13-31)33(19)25(34)21-4-1-2-5-22(21)28/h1-11,19-20H,12-16H2 BWKWPOJXIVYIEJ-UHFFFAOYSA-N 515534 US11098063, Example 30 Potassium channel subfamily K member 3 Human 3500 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515534 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515534&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 147164195 461601640 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082153 Fc1ccccc1C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H23ClFN5O2/c27-18-8-6-17(7-9-18)24-23(32-11-3-10-29-26(32)30-24)14-31-12-19-15-35-16-20(13-31)33(19)25(34)21-4-1-2-5-22(21)28/h1-11,19-20H,12-16H2 BWKWPOJXIVYIEJ-UHFFFAOYSA-N 515534 US11098063, Example 30 Potassium channel subfamily K member 9 Homo sapiens 85.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515534 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515534&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 147164195 461601640 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082154 COc1cccc(c1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C27H26ClN5O3/c1-35-23-5-2-4-19(12-23)26(34)33-21-13-31(14-22(33)17-36-16-21)15-24-25(18-6-8-20(28)9-7-18)30-27-29-10-3-11-32(24)27/h2-12,21-22H,13-17H2,1H3 UHWYXFPQZKPERO-UHFFFAOYSA-N 515535 US11098063, Example 31 Potassium channel subfamily K member 3 Human 7100 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515535 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515535&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475144 461601641 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082155 COc1cccc(c1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C27H26ClN5O3/c1-35-23-5-2-4-19(12-23)26(34)33-21-13-31(14-22(33)17-36-16-21)15-24-25(18-6-8-20(28)9-7-18)30-27-29-10-3-11-32(24)27/h2-12,21-22H,13-17H2,1H3 UHWYXFPQZKPERO-UHFFFAOYSA-N 515535 US11098063, Example 31 Potassium channel subfamily K member 9 Homo sapiens 140 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515535 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515535&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475144 461601641 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082156 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H23ClFN5O/c27-18-8-6-17(7-9-18)24-23(32-13-3-12-29-26(32)30-24)16-31-14-19-10-11-20(15-31)33(19)25(34)21-4-1-2-5-22(21)28/h1-9,12-13,19-20H,10-11,14-16H2 YBFWIANGKAZADX-UHFFFAOYSA-N 515536 US11098063, Example 32 Potassium channel subfamily K member 3 Human 370 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515536 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515536&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 149325271 461601642 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082157 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H23ClFN5O/c27-18-8-6-17(7-9-18)24-23(32-13-3-12-29-26(32)30-24)16-31-14-19-10-11-20(15-31)33(19)25(34)21-4-1-2-5-22(21)28/h1-9,12-13,19-20H,10-11,14-16H2 YBFWIANGKAZADX-UHFFFAOYSA-N 515536 US11098063, Example 32 Potassium channel subfamily K member 9 Homo sapiens 29.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515536 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515536&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 149325271 461601642 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082158 CSc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H25ClN6OS/c1-35-23-5-2-4-21(29-23)25(34)33-19-10-11-20(33)15-31(14-19)16-22-24(17-6-8-18(27)9-7-17)30-26-28-12-3-13-32(22)26/h2-9,12-13,19-20H,10-11,14-16H2,1H3 GYRMHJVFDKQGNT-UHFFFAOYSA-N 515537 US11098063, Example 33 Potassium channel subfamily K member 3 Human 190 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515537 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515537&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 147732394 461601643 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082159 CSc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H25ClN6OS/c1-35-23-5-2-4-21(29-23)25(34)33-19-10-11-20(33)15-31(14-19)16-22-24(17-6-8-18(27)9-7-17)30-26-28-12-3-13-32(22)26/h2-9,12-13,19-20H,10-11,14-16H2,1H3 GYRMHJVFDKQGNT-UHFFFAOYSA-N 515537 US11098063, Example 33 Potassium channel subfamily K member 9 Homo sapiens 130 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515537 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515537&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 147732394 461601643 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082160 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)C1CCCC1 InChI=1S/C25H28ClN5O/c26-19-8-6-17(7-9-19)23-22(30-13-3-12-27-25(30)28-23)16-29-14-20-10-11-21(15-29)31(20)24(32)18-4-1-2-5-18/h3,6-9,12-13,18,20-21H,1-2,4-5,10-11,14-16H2 QYTQZGPBDSWPLU-UHFFFAOYSA-N 515538 US11098063, Example 34 Potassium channel subfamily K member 3 Human 76.0 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515538 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515538&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 149117053 461601644 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082161 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)C1CCCC1 InChI=1S/C25H28ClN5O/c26-19-8-6-17(7-9-19)23-22(30-13-3-12-27-25(30)28-23)16-29-14-20-10-11-21(15-29)31(20)24(32)18-4-1-2-5-18/h3,6-9,12-13,18,20-21H,1-2,4-5,10-11,14-16H2 QYTQZGPBDSWPLU-UHFFFAOYSA-N 515538 US11098063, Example 34 Potassium channel subfamily K member 9 Homo sapiens 29.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515538 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515538&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 149117053 461601644 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082162 CNc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H26ClN7O/c1-28-23-5-2-4-21(30-23)25(35)34-19-10-11-20(34)15-32(14-19)16-22-24(17-6-8-18(27)9-7-17)31-26-29-12-3-13-33(22)26/h2-9,12-13,19-20H,10-11,14-16H2,1H3,(H,28,30) CIEJXXZZDSIUDI-UHFFFAOYSA-N 515539 US11098063, Example 35 Potassium channel subfamily K member 3 Human 6700 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515539 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515539&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 147227042 461601645 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082163 CNc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H26ClN7O/c1-28-23-5-2-4-21(30-23)25(35)34-19-10-11-20(34)15-32(14-19)16-22-24(17-6-8-18(27)9-7-17)31-26-29-12-3-13-33(22)26/h2-9,12-13,19-20H,10-11,14-16H2,1H3,(H,28,30) CIEJXXZZDSIUDI-UHFFFAOYSA-N 515539 US11098063, Example 35 Potassium channel subfamily K member 9 Homo sapiens 1500 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515539 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515539&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 147227042 461601645 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082164 COc1cccc(c1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C27H26ClN5O2/c1-35-23-5-2-4-19(14-23)26(34)33-21-10-11-22(33)16-31(15-21)17-24-25(18-6-8-20(28)9-7-18)30-27-29-12-3-13-32(24)27/h2-9,12-14,21-22H,10-11,15-17H2,1H3 UHHZPHHGXIXMBI-UHFFFAOYSA-N 515540 US11098063, Example 36 Potassium channel subfamily K member 3 Human 310 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515540 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515540&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 152911646 461601646 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082165 COc1cccc(c1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C27H26ClN5O2/c1-35-23-5-2-4-19(14-23)26(34)33-21-10-11-22(33)16-31(15-21)17-24-25(18-6-8-20(28)9-7-18)30-27-29-12-3-13-32(24)27/h2-9,12-14,21-22H,10-11,15-17H2,1H3 UHHZPHHGXIXMBI-UHFFFAOYSA-N 515540 US11098063, Example 36 Potassium channel subfamily K member 9 Homo sapiens 80.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515540 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515540&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 152911646 461601646 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082166 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CN2C(=O)C1CCCC1 InChI=1S/C25H28ClN5O/c26-19-8-6-17(7-9-19)23-22(30-13-3-12-27-25(30)28-23)16-29-14-21-11-10-20(29)15-31(21)24(32)18-4-1-2-5-18/h3,6-9,12-13,18,20-21H,1-2,4-5,10-11,14-16H2 KAEXILIURFXOFG-UHFFFAOYSA-N 515541 US11098063, Example 37 Potassium channel subfamily K member 3 Human 1500 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515541 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515541&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148158410 461601647 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082167 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CN2C(=O)C1CCCC1 InChI=1S/C25H28ClN5O/c26-19-8-6-17(7-9-19)23-22(30-13-3-12-27-25(30)28-23)16-29-14-21-11-10-20(29)15-31(21)24(32)18-4-1-2-5-18/h3,6-9,12-13,18,20-21H,1-2,4-5,10-11,14-16H2 KAEXILIURFXOFG-UHFFFAOYSA-N 515541 US11098063, Example 37 Potassium channel subfamily K member 9 Homo sapiens 140 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515541 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515541&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148158410 461601647 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082168 COc1cccc(c1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H26ClN5O2/c1-35-23-5-2-4-19(14-23)26(34)33-16-21-10-11-22(33)15-31(21)17-24-25(18-6-8-20(28)9-7-18)30-27-29-12-3-13-32(24)27/h2-9,12-14,21-22H,10-11,15-17H2,1H3 FREVYYBUHULBEQ-UHFFFAOYSA-N 515542 US11098063, Example 38::US11098063, Example 43 Potassium channel subfamily K member 3 Human 9600 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515542&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 147553318 461601648 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082169 COc1cccc(c1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H26ClN5O2/c1-35-23-5-2-4-19(14-23)26(34)33-16-21-10-11-22(33)15-31(21)17-24-25(18-6-8-20(28)9-7-18)30-27-29-12-3-13-32(24)27/h2-9,12-14,21-22H,10-11,15-17H2,1H3 FREVYYBUHULBEQ-UHFFFAOYSA-N 515542 US11098063, Example 38::US11098063, Example 43 Potassium channel subfamily K member 9 Homo sapiens 320 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515542&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 147553318 461601648 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082170 Fc1ccccc1C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H23ClFN5O/c27-18-8-6-17(7-9-18)24-23(32-13-3-12-29-26(32)30-24)16-31-14-20-11-10-19(31)15-33(20)25(34)21-4-1-2-5-22(21)28/h1-9,12-13,19-20H,10-11,14-16H2 WCQRINNANFQKBJ-UHFFFAOYSA-N 515543 US11098063, Example 39::US11098063, Example 42 Potassium channel subfamily K member 3 Human 1400 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515543&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 152237741 461601649 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082171 Fc1ccccc1C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H23ClFN5O/c27-18-8-6-17(7-9-18)24-23(32-13-3-12-29-26(32)30-24)16-31-14-20-11-10-19(31)15-33(20)25(34)21-4-1-2-5-22(21)28/h1-9,12-13,19-20H,10-11,14-16H2 WCQRINNANFQKBJ-UHFFFAOYSA-N 515543 US11098063, Example 39::US11098063, Example 42 Potassium channel subfamily K member 9 Homo sapiens 160 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515543&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 152237741 461601649 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082172 COc1cccc(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H25ClN6O2/c1-35-23-5-2-4-21(29-23)25(34)33-15-19-10-11-20(33)14-31(19)16-22-24(17-6-8-18(27)9-7-17)30-26-28-12-3-13-32(22)26/h2-9,12-13,19-20H,10-11,14-16H2,1H3 LLTPOYYYCGQMEU-UHFFFAOYSA-N 515544 US11098063, Example 40::US11098063, Example 44 Potassium channel subfamily K member 3 Human 5700 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515544 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515544&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148368106 461601650 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082173 COc1cccc(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H25ClN6O2/c1-35-23-5-2-4-21(29-23)25(34)33-15-19-10-11-20(33)14-31(19)16-22-24(17-6-8-18(27)9-7-17)30-26-28-12-3-13-32(22)26/h2-9,12-13,19-20H,10-11,14-16H2,1H3 LLTPOYYYCGQMEU-UHFFFAOYSA-N 515544 US11098063, Example 40::US11098063, Example 44 Potassium channel subfamily K member 9 Homo sapiens 210 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515544 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515544&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148368106 461601650 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082174 COc1ccc(F)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H24ClFN6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-14-18-7-8-19(34)13-32(18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 LLVGWHFNQXAKJW-UHFFFAOYSA-N 515514 US11098063, Example 24::US11098063, Example 41 Potassium channel subfamily K member 3 Human 1500 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515514&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462905 461601621 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082175 COc1ccc(F)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H24ClFN6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-14-18-7-8-19(34)13-32(18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 LLVGWHFNQXAKJW-UHFFFAOYSA-N 515514 US11098063, Example 24::US11098063, Example 41 Potassium channel subfamily K member 9 Homo sapiens 100.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515514&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462905 461601621 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082176 Fc1ccccc1C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H23ClFN5O/c27-18-8-6-17(7-9-18)24-23(32-13-3-12-29-26(32)30-24)16-31-14-20-11-10-19(31)15-33(20)25(34)21-4-1-2-5-22(21)28/h1-9,12-13,19-20H,10-11,14-16H2 WCQRINNANFQKBJ-UHFFFAOYSA-N 515543 US11098063, Example 39::US11098063, Example 42 Potassium channel subfamily K member 3 Human 1000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515543&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 152237741 461601649 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082177 Fc1ccccc1C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H23ClFN5O/c27-18-8-6-17(7-9-18)24-23(32-13-3-12-29-26(32)30-24)16-31-14-20-11-10-19(31)15-33(20)25(34)21-4-1-2-5-22(21)28/h1-9,12-13,19-20H,10-11,14-16H2 WCQRINNANFQKBJ-UHFFFAOYSA-N 515543 US11098063, Example 39::US11098063, Example 42 Potassium channel subfamily K member 9 Homo sapiens 340 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515543&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 152237741 461601649 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082178 COc1cccc(c1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H26ClN5O2/c1-35-23-5-2-4-19(14-23)26(34)33-16-21-10-11-22(33)15-31(21)17-24-25(18-6-8-20(28)9-7-18)30-27-29-12-3-13-32(24)27/h2-9,12-14,21-22H,10-11,15-17H2,1H3 FREVYYBUHULBEQ-UHFFFAOYSA-N 515542 US11098063, Example 38::US11098063, Example 43 Potassium channel subfamily K member 3 Human 1000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515542&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 147553318 461601648 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082179 COc1cccc(c1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H26ClN5O2/c1-35-23-5-2-4-19(14-23)26(34)33-16-21-10-11-22(33)15-31(21)17-24-25(18-6-8-20(28)9-7-18)30-27-29-12-3-13-32(24)27/h2-9,12-14,21-22H,10-11,15-17H2,1H3 FREVYYBUHULBEQ-UHFFFAOYSA-N 515542 US11098063, Example 38::US11098063, Example 43 Potassium channel subfamily K member 9 Homo sapiens 320 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515542&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 147553318 461601648 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082180 COc1cccc(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H25ClN6O2/c1-35-23-5-2-4-21(29-23)25(34)33-15-19-10-11-20(33)14-31(19)16-22-24(17-6-8-18(27)9-7-17)30-26-28-12-3-13-32(22)26/h2-9,12-13,19-20H,10-11,14-16H2,1H3 LLTPOYYYCGQMEU-UHFFFAOYSA-N 515544 US11098063, Example 40::US11098063, Example 44 Potassium channel subfamily K member 3 Human 1000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515544 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515544&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148368106 461601650 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082181 COc1cccc(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H25ClN6O2/c1-35-23-5-2-4-21(29-23)25(34)33-15-19-10-11-20(33)14-31(19)16-22-24(17-6-8-18(27)9-7-17)30-26-28-12-3-13-32(22)26/h2-9,12-13,19-20H,10-11,14-16H2,1H3 LLTPOYYYCGQMEU-UHFFFAOYSA-N 515544 US11098063, Example 40::US11098063, Example 44 Potassium channel subfamily K member 9 Homo sapiens 190 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515544 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515544&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148368106 461601650 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082182 COc1ccc(Cl)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H24Cl2N6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-14-18-7-8-19(34)13-32(18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 DAKTUVDDMZBJNU-UHFFFAOYSA-N 515531 (3-Chloro-6-methoxypyridin-2-yl)(5-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 1)::US11098063, Example 23::US11098063, Example 45 Potassium channel subfamily K member 3 Human 1800 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515531 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515531&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462654 461601638 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082183 COc1ccc(Cl)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C26H24Cl2N6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-14-18-7-8-19(34)13-32(18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 DAKTUVDDMZBJNU-UHFFFAOYSA-N 515531 (3-Chloro-6-methoxypyridin-2-yl)(5-{[2-(4-chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 1)::US11098063, Example 23::US11098063, Example 45 Potassium channel subfamily K member 9 Homo sapiens 120 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515531 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515531&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462654 461601638 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082184 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2COCC(C1)N2C(=O)c1ncoc1C1CC1 InChI=1S/C26H25ClN6O3/c27-18-6-4-16(5-7-18)22-21(32-9-1-8-28-26(32)30-22)12-31-10-19-13-35-14-20(11-31)33(19)25(34)23-24(17-2-3-17)36-15-29-23/h1,4-9,15,17,19-20H,2-3,10-14H2 ZEUWISZLQVQAMH-UHFFFAOYSA-N 515549 US11098063, Example 46 Potassium channel subfamily K member 3 Human 7600 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515549&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 149489501 461601651 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082185 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2COCC(C1)N2C(=O)c1ncoc1C1CC1 InChI=1S/C26H25ClN6O3/c27-18-6-4-16(5-7-18)22-21(32-9-1-8-28-26(32)30-22)12-31-10-19-13-35-14-20(11-31)33(19)25(34)23-24(17-2-3-17)36-15-29-23/h1,4-9,15,17,19-20H,2-3,10-14H2 ZEUWISZLQVQAMH-UHFFFAOYSA-N 515549 US11098063, Example 46 Potassium channel subfamily K member 9 Homo sapiens 140 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515549&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 149489501 461601651 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082186 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)c1coc(n1)C1CC1 InChI=1S/C26H25ClN6O2/c27-18-6-4-16(5-7-18)23-22(32-11-1-10-28-26(32)30-23)14-31-12-19-8-9-20(13-31)33(19)25(34)21-15-35-24(29-21)17-2-3-17/h1,4-7,10-11,15,17,19-20H,2-3,8-9,12-14H2 XKRLEBDFZMKVKU-UHFFFAOYSA-N 515550 US11098063, Example 47 Potassium channel subfamily K member 3 Human 2800 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515550&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 149233070 461601652 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082187 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)c1coc(n1)C1CC1 InChI=1S/C26H25ClN6O2/c27-18-6-4-16(5-7-18)23-22(32-11-1-10-28-26(32)30-23)14-31-12-19-8-9-20(13-31)33(19)25(34)21-15-35-24(29-21)17-2-3-17/h1,4-7,10-11,15,17,19-20H,2-3,8-9,12-14H2 XKRLEBDFZMKVKU-UHFFFAOYSA-N 515550 US11098063, Example 47 Potassium channel subfamily K member 9 Homo sapiens 110 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515550&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 149233070 461601652 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082188 Cc1ocnc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H23ClN6O2/c1-15-21(27-14-33-15)23(32)31-18-7-8-19(31)12-29(11-18)13-20-22(16-3-5-17(25)6-4-16)28-24-26-9-2-10-30(20)24/h2-6,9-10,14,18-19H,7-8,11-13H2,1H3 HYWPRKJMSJGCHY-UHFFFAOYSA-N 515551 US11098063, Example 48 Potassium channel subfamily K member 3 Human 400 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515551&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475151 461601653 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082189 Cc1ocnc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H23ClN6O2/c1-15-21(27-14-33-15)23(32)31-18-7-8-19(31)12-29(11-18)13-20-22(16-3-5-17(25)6-4-16)28-24-26-9-2-10-30(20)24/h2-6,9-10,14,18-19H,7-8,11-13H2,1H3 HYWPRKJMSJGCHY-UHFFFAOYSA-N 515551 US11098063, Example 48 Potassium channel subfamily K member 9 Homo sapiens 23.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515551&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475151 461601653 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082190 CC(C)c1ocnc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H27ClN6O2/c1-16(2)24-23(29-15-35-24)25(34)33-19-8-9-20(33)13-31(12-19)14-21-22(17-4-6-18(27)7-5-17)30-26-28-10-3-11-32(21)26/h3-7,10-11,15-16,19-20H,8-9,12-14H2,1-2H3 UHTJGZXPGMCUFT-UHFFFAOYSA-N 515552 US11098063, Example 49 Potassium channel subfamily K member 3 Human 260 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515552&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475165 461601654 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082191 CC(C)c1ocnc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H27ClN6O2/c1-16(2)24-23(29-15-35-24)25(34)33-19-8-9-20(33)13-31(12-19)14-21-22(17-4-6-18(27)7-5-17)30-26-28-10-3-11-32(21)26/h3-7,10-11,15-16,19-20H,8-9,12-14H2,1-2H3 UHTJGZXPGMCUFT-UHFFFAOYSA-N 515552 US11098063, Example 49 Potassium channel subfamily K member 9 Homo sapiens 12.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515552&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475165 461601654 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082192 Cc1nc(C)c(o1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C25H25ClN6O2/c1-15-23(34-16(2)28-15)24(33)32-19-8-9-20(32)13-30(12-19)14-21-22(17-4-6-18(26)7-5-17)29-25-27-10-3-11-31(21)25/h3-7,10-11,19-20H,8-9,12-14H2,1-2H3 BYOPFMQSZFZVGW-UHFFFAOYSA-N 515553 US11098063, Example 50 Potassium channel subfamily K member 3 Human 3300 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515553&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475150 461601655 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082193 Cc1nc(C)c(o1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C25H25ClN6O2/c1-15-23(34-16(2)28-15)24(33)32-19-8-9-20(32)13-30(12-19)14-21-22(17-4-6-18(26)7-5-17)29-25-27-10-3-11-31(21)25/h3-7,10-11,19-20H,8-9,12-14H2,1-2H3 BYOPFMQSZFZVGW-UHFFFAOYSA-N 515553 US11098063, Example 50 Potassium channel subfamily K member 9 Homo sapiens 430 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515553&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475150 461601655 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082194 CCc1ocnc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C25H25ClN6O2/c1-2-21-23(28-15-34-21)24(33)32-18-8-9-19(32)13-30(12-18)14-20-22(16-4-6-17(26)7-5-16)29-25-27-10-3-11-31(20)25/h3-7,10-11,15,18-19H,2,8-9,12-14H2,1H3 UVWUDBXLAOOGPT-UHFFFAOYSA-N 515515 US11098063, Example 51 Potassium channel subfamily K member 3 Human 250 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515515 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515515&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475149 461601622 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082195 CCc1ocnc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C25H25ClN6O2/c1-2-21-23(28-15-34-21)24(33)32-18-8-9-19(32)13-30(12-18)14-20-22(16-4-6-17(26)7-5-16)29-25-27-10-3-11-31(20)25/h3-7,10-11,15,18-19H,2,8-9,12-14H2,1H3 UVWUDBXLAOOGPT-UHFFFAOYSA-N 515515 US11098063, Example 51 Potassium channel subfamily K member 9 Homo sapiens 8.70 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515515 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515515&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475149 461601622 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082196 Cc1sc(nc1Br)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H22BrClN6OS/c1-14-21(25)29-22(34-14)23(33)32-17-7-8-18(32)12-30(11-17)13-19-20(15-3-5-16(26)6-4-15)28-24-27-9-2-10-31(19)24/h2-6,9-10,17-18H,7-8,11-13H2,1H3 LVNYRFABBREFGB-UHFFFAOYSA-N 515554 US11098063, Example 52 Potassium channel subfamily K member 3 Human 1300 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515554&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148420795 461601656 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082197 Cc1sc(nc1Br)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H22BrClN6OS/c1-14-21(25)29-22(34-14)23(33)32-17-7-8-18(32)12-30(11-17)13-19-20(15-3-5-16(26)6-4-15)28-24-27-9-2-10-31(19)24/h2-6,9-10,17-18H,7-8,11-13H2,1H3 LVNYRFABBREFGB-UHFFFAOYSA-N 515554 US11098063, Example 52 Potassium channel subfamily K member 9 Homo sapiens 52.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515554&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148420795 461601656 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082198 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)c1ncoc1C1CC1 InChI=1S/C26H25ClN6O2/c27-18-6-4-16(5-7-18)22-21(32-11-1-10-28-26(32)30-22)14-31-12-19-8-9-20(13-31)33(19)25(34)23-24(17-2-3-17)35-15-29-23/h1,4-7,10-11,15,17,19-20H,2-3,8-9,12-14H2 VBTYXWBNGSZKIF-UHFFFAOYSA-N 515555 US11098063, Example 53 Potassium channel subfamily K member 3 Human 620 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515555&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153020228 461601657 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082199 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)c1ncoc1C1CC1 InChI=1S/C26H25ClN6O2/c27-18-6-4-16(5-7-18)22-21(32-11-1-10-28-26(32)30-22)14-31-12-19-8-9-20(13-31)33(19)25(34)23-24(17-2-3-17)35-15-29-23/h1,4-7,10-11,15,17,19-20H,2-3,8-9,12-14H2 VBTYXWBNGSZKIF-UHFFFAOYSA-N 515555 US11098063, Example 53 Potassium channel subfamily K member 9 Homo sapiens 19.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515555&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153020228 461601657 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082200 CC(C)c1nc(cs1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H27ClN6OS/c1-16(2)24-29-21(15-35-24)25(34)33-19-8-9-20(33)13-31(12-19)14-22-23(17-4-6-18(27)7-5-17)30-26-28-10-3-11-32(22)26/h3-7,10-11,15-16,19-20H,8-9,12-14H2,1-2H3 IWCKEDCEPORMDB-UHFFFAOYSA-N 515556 US11098063, Example 54 Potassium channel subfamily K member 3 Human 860 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515556 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515556&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475163 461601658 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082201 CC(C)c1nc(cs1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H27ClN6OS/c1-16(2)24-29-21(15-35-24)25(34)33-19-8-9-20(33)13-31(12-19)14-22-23(17-4-6-18(27)7-5-17)30-26-28-10-3-11-32(22)26/h3-7,10-11,15-16,19-20H,8-9,12-14H2,1-2H3 IWCKEDCEPORMDB-UHFFFAOYSA-N 515556 US11098063, Example 54 Potassium channel subfamily K member 9 Homo sapiens 13.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515556 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515556&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475163 461601658 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082202 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)c1cncs1 InChI=1S/C23H21ClN6OS/c24-16-4-2-15(3-5-16)21-19(29-9-1-8-26-23(29)27-21)13-28-11-17-6-7-18(12-28)30(17)22(31)20-10-25-14-32-20/h1-5,8-10,14,17-18H,6-7,11-13H2 NIIMIDSEQIZCCP-UHFFFAOYSA-N 515557 US11098063, Example 55 Potassium channel subfamily K member 3 Human 2900 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515557&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148632049 461601659 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082203 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)c1cncs1 InChI=1S/C23H21ClN6OS/c24-16-4-2-15(3-5-16)21-19(29-9-1-8-26-23(29)27-21)13-28-11-17-6-7-18(12-28)30(17)22(31)20-10-25-14-32-20/h1-5,8-10,14,17-18H,6-7,11-13H2 NIIMIDSEQIZCCP-UHFFFAOYSA-N 515557 US11098063, Example 55 Potassium channel subfamily K member 9 Homo sapiens 170 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515557&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148632049 461601659 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082204 Cc1nc(C(=O)N2C3CCC2CN(Cc2c(nc4ncccn24)-c2ccc(Cl)cc2)C3)c(C)o1 InChI=1S/C25H25ClN6O2/c1-15-22(28-16(2)34-15)24(33)32-19-8-9-20(32)13-30(12-19)14-21-23(17-4-6-18(26)7-5-17)29-25-27-10-3-11-31(21)25/h3-7,10-11,19-20H,8-9,12-14H2,1-2H3 FYZNINRWEUSAQT-UHFFFAOYSA-N 515558 US11098063, Example 56 Potassium channel subfamily K member 3 Human 5600 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515558 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515558&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 147594908 461601660 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082205 Cc1nc(C(=O)N2C3CCC2CN(Cc2c(nc4ncccn24)-c2ccc(Cl)cc2)C3)c(C)o1 InChI=1S/C25H25ClN6O2/c1-15-22(28-16(2)34-15)24(33)32-19-8-9-20(32)13-30(12-19)14-21-23(17-4-6-18(26)7-5-17)29-25-27-10-3-11-31(21)25/h3-7,10-11,19-20H,8-9,12-14H2,1-2H3 FYZNINRWEUSAQT-UHFFFAOYSA-N 515558 US11098063, Example 56 Potassium channel subfamily K member 9 Homo sapiens 54.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515558 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515558&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 147594908 461601660 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082206 COc1nc(c(s1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2)C(F)(F)F InChI=1S/C25H22ClF3N6O2S/c1-37-24-32-21(25(27,28)29)20(38-24)22(36)35-16-7-8-17(35)12-33(11-16)13-18-19(14-3-5-15(26)6-4-14)31-23-30-9-2-10-34(18)23/h2-6,9-10,16-17H,7-8,11-13H2,1H3 RMDZSEVELQYTJH-UHFFFAOYSA-N 515559 US11098063, Example 57 Potassium channel subfamily K member 3 Human 6400 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515559&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146746797 461601661 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082207 COc1nc(c(s1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2)C(F)(F)F InChI=1S/C25H22ClF3N6O2S/c1-37-24-32-21(25(27,28)29)20(38-24)22(36)35-16-7-8-17(35)12-33(11-16)13-18-19(14-3-5-15(26)6-4-14)31-23-30-9-2-10-34(18)23/h2-6,9-10,16-17H,7-8,11-13H2,1H3 RMDZSEVELQYTJH-UHFFFAOYSA-N 515559 US11098063, Example 57 Potassium channel subfamily K member 9 Homo sapiens 57.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515559&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146746797 461601661 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082208 FC(F)(F)c1nc(cs1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H20ClF3N6OS/c25-15-4-2-14(3-5-15)20-19(33-9-1-8-29-23(33)31-20)12-32-10-16-6-7-17(11-32)34(16)21(35)18-13-36-22(30-18)24(26,27)28/h1-5,8-9,13,16-17H,6-7,10-12H2 FDAHMGGPHSJZAW-UHFFFAOYSA-N 515560 US11098063, Example 58 Potassium channel subfamily K member 3 Human 1600 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515560&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 147477788 461601662 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082209 FC(F)(F)c1nc(cs1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H20ClF3N6OS/c25-15-4-2-14(3-5-15)20-19(33-9-1-8-29-23(33)31-20)12-32-10-16-6-7-17(11-32)34(16)21(35)18-13-36-22(30-18)24(26,27)28/h1-5,8-9,13,16-17H,6-7,10-12H2 FDAHMGGPHSJZAW-UHFFFAOYSA-N 515560 US11098063, Example 58 Potassium channel subfamily K member 9 Homo sapiens 17.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515560&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 147477788 461601662 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082210 Cc1scnc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H23ClN6OS/c1-15-21(27-14-33-15)23(32)31-18-7-8-19(31)12-29(11-18)13-20-22(16-3-5-17(25)6-4-16)28-24-26-9-2-10-30(20)24/h2-6,9-10,14,18-19H,7-8,11-13H2,1H3 ZMUGIMALNFGEQA-UHFFFAOYSA-N 515561 US11098063, Example 59 Potassium channel subfamily K member 3 Human 3000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515561&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 149531885 461601663 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082211 Cc1scnc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H23ClN6OS/c1-15-21(27-14-33-15)23(32)31-18-7-8-19(31)12-29(11-18)13-20-22(16-3-5-17(25)6-4-16)28-24-26-9-2-10-30(20)24/h2-6,9-10,14,18-19H,7-8,11-13H2,1H3 ZMUGIMALNFGEQA-UHFFFAOYSA-N 515561 US11098063, Example 59 Potassium channel subfamily K member 9 Homo sapiens 39.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515561&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 149531885 461601663 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082212 FC(F)(F)c1csc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H20ClF3N6OS/c25-15-4-2-14(3-5-15)20-18(33-9-1-8-29-23(33)31-20)12-32-10-16-6-7-17(11-32)34(16)22(35)21-30-19(13-36-21)24(26,27)28/h1-5,8-9,13,16-17H,6-7,10-12H2 XPWVLPCXZWXDRZ-UHFFFAOYSA-N 515562 US11098063, Example 60 Potassium channel subfamily K member 3 Human 670 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515562&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 155717791 461601664 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082213 FC(F)(F)c1csc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H20ClF3N6OS/c25-15-4-2-14(3-5-15)20-18(33-9-1-8-29-23(33)31-20)12-32-10-16-6-7-17(11-32)34(16)22(35)21-30-19(13-36-21)24(26,27)28/h1-5,8-9,13,16-17H,6-7,10-12H2 XPWVLPCXZWXDRZ-UHFFFAOYSA-N 515562 US11098063, Example 60 Potassium channel subfamily K member 9 Homo sapiens 430 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515562&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 155717791 461601664 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082214 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)c1cscn1 InChI=1S/C23H21ClN6OS/c24-16-4-2-15(3-5-16)21-20(29-9-1-8-25-23(29)27-21)12-28-10-17-6-7-18(11-28)30(17)22(31)19-13-32-14-26-19/h1-5,8-9,13-14,17-18H,6-7,10-12H2 PUGCCFFAORWRLJ-UHFFFAOYSA-N 515563 US11098063, Example 61 Potassium channel subfamily K member 3 Human 3000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515563&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475143 461601665 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082215 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)c1cscn1 InChI=1S/C23H21ClN6OS/c24-16-4-2-15(3-5-16)21-20(29-9-1-8-25-23(29)27-21)12-28-10-17-6-7-18(11-28)30(17)22(31)19-13-32-14-26-19/h1-5,8-9,13-14,17-18H,6-7,10-12H2 PUGCCFFAORWRLJ-UHFFFAOYSA-N 515563 US11098063, Example 61 Potassium channel subfamily K member 9 Homo sapiens 640 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515563&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475143 461601665 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082216 CNc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H33N7O/c1-19(2)20-8-10-21(11-9-20)27-25(35-15-5-14-31-29(35)33-27)18-34-16-22-12-13-23(17-34)36(22)28(37)24-6-4-7-26(30-3)32-24/h4-11,14-15,19,22-23H,12-13,16-18H2,1-3H3,(H,30,32) FKMSGXPQSHPADM-UHFFFAOYSA-N 515564 US11098063, Example 62 Potassium channel subfamily K member 3 Human 6900 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515564&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475152 461601666 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082217 CNc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H33N7O/c1-19(2)20-8-10-21(11-9-20)27-25(35-15-5-14-31-29(35)33-27)18-34-16-22-12-13-23(17-34)36(22)28(37)24-6-4-7-26(30-3)32-24/h4-11,14-15,19,22-23H,12-13,16-18H2,1-3H3,(H,30,32) FKMSGXPQSHPADM-UHFFFAOYSA-N 515564 US11098063, Example 62 Potassium channel subfamily K member 9 Homo sapiens 70.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515564&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475152 461601666 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082218 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H32N6O2/c1-19(2)20-8-10-21(11-9-20)27-25(34-15-5-14-30-29(34)32-27)18-33-16-22-12-13-23(17-33)35(22)28(36)24-6-4-7-26(31-24)37-3/h4-11,14-15,19,22-23H,12-13,16-18H2,1-3H3 IXRMFHMGDSBECB-UHFFFAOYSA-N 515565 US11098063, Example 63 Potassium channel subfamily K member 3 Human 1700 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515565&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475147 461601667 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082219 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H32N6O2/c1-19(2)20-8-10-21(11-9-20)27-25(34-15-5-14-30-29(34)32-27)18-33-16-22-12-13-23(17-33)35(22)28(36)24-6-4-7-26(31-24)37-3/h4-11,14-15,19,22-23H,12-13,16-18H2,1-3H3 IXRMFHMGDSBECB-UHFFFAOYSA-N 515565 US11098063, Example 63 Potassium channel subfamily K member 9 Homo sapiens 15.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515565&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475147 461601667 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082220 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)c1ccccc1F InChI=1S/C29H30FN5O/c1-19(2)20-8-10-21(11-9-20)27-26(34-15-5-14-31-29(34)32-27)18-33-16-22-12-13-23(17-33)35(22)28(36)24-6-3-4-7-25(24)30/h3-11,14-15,19,22-23H,12-13,16-18H2,1-2H3 UEUVBXDERHQXLA-UHFFFAOYSA-N 515566 US11098063, Example 64 Potassium channel subfamily K member 3 Human 1100 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515566&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475161 461601668 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082221 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)c1ccccc1F InChI=1S/C29H30FN5O/c1-19(2)20-8-10-21(11-9-20)27-26(34-15-5-14-31-29(34)32-27)18-33-16-22-12-13-23(17-33)35(22)28(36)24-6-3-4-7-25(24)30/h3-11,14-15,19,22-23H,12-13,16-18H2,1-2H3 UEUVBXDERHQXLA-UHFFFAOYSA-N 515566 US11098063, Example 64 Potassium channel subfamily K member 9 Homo sapiens 8.40 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515566&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475161 461601668 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082222 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H24ClFN6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-18-7-8-19(34)14-32(13-18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 SMVLTESEHRAPDU-UHFFFAOYSA-N 515567 US11098063, Example 65 Potassium channel subfamily K member 3 Human 3500 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515567&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462748 461601669 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082223 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H24ClFN6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-18-7-8-19(34)14-32(13-18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 SMVLTESEHRAPDU-UHFFFAOYSA-N 515567 US11098063, Example 65 Potassium channel subfamily K member 9 Homo sapiens 670 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515567&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462748 461601669 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082224 COc1cccc(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H32N6O3/c1-19(2)20-8-10-21(11-9-20)27-25(34-13-5-12-30-29(34)32-27)16-33-14-22-17-38-18-23(15-33)35(22)28(36)24-6-4-7-26(31-24)37-3/h4-13,19,22-23H,14-18H2,1-3H3 RNNRYDYURIFVOM-UHFFFAOYSA-N 515568 US11098063, Example 66 Potassium channel subfamily K member 3 Human 3700 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515568&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475159 461601670 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082225 COc1cccc(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H32N6O3/c1-19(2)20-8-10-21(11-9-20)27-25(34-13-5-12-30-29(34)32-27)16-33-14-22-17-38-18-23(15-33)35(22)28(36)24-6-4-7-26(31-24)37-3/h4-13,19,22-23H,14-18H2,1-3H3 RNNRYDYURIFVOM-UHFFFAOYSA-N 515568 US11098063, Example 66 Potassium channel subfamily K member 9 Homo sapiens 20.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515568&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475159 461601670 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082226 COc1ccc(Cl)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H31ClN6O3/c1-18(2)19-5-7-20(8-6-19)26-24(35-12-4-11-31-29(35)33-26)15-34-13-21-16-39-17-22(14-34)36(21)28(37)27-23(30)9-10-25(32-27)38-3/h4-12,18,21-22H,13-17H2,1-3H3 BFROTJLKWLVNAW-UHFFFAOYSA-N 515569 US11098063, Example 67 Potassium channel subfamily K member 3 Human 1200 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515569&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475153 461601671 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082227 COc1ccc(Cl)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)C2 InChI=1S/C29H31ClN6O3/c1-18(2)19-5-7-20(8-6-19)26-24(35-12-4-11-31-29(35)33-26)15-34-13-21-16-39-17-22(14-34)36(21)28(37)27-23(30)9-10-25(32-27)38-3/h4-12,18,21-22H,13-17H2,1-3H3 BFROTJLKWLVNAW-UHFFFAOYSA-N 515569 US11098063, Example 67 Potassium channel subfamily K member 9 Homo sapiens 17.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515569&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475153 461601671 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082228 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2COCC(C1)N2C(=O)c1ccccc1F InChI=1S/C29H30FN5O2/c1-19(2)20-8-10-21(11-9-20)27-26(34-13-5-12-31-29(34)32-27)16-33-14-22-17-37-18-23(15-33)35(22)28(36)24-6-3-4-7-25(24)30/h3-13,19,22-23H,14-18H2,1-2H3 BKNDMWLGGMBYTD-UHFFFAOYSA-N 515570 US11098063, Example 68 Potassium channel subfamily K member 3 Human 9400 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515570&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 147100270 461601672 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082229 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2COCC(C1)N2C(=O)c1ccccc1F InChI=1S/C29H30FN5O2/c1-19(2)20-8-10-21(11-9-20)27-26(34-13-5-12-31-29(34)32-27)16-33-14-22-17-37-18-23(15-33)35(22)28(36)24-6-3-4-7-25(24)30/h3-13,19,22-23H,14-18H2,1-2H3 BKNDMWLGGMBYTD-UHFFFAOYSA-N 515570 US11098063, Example 68 Potassium channel subfamily K member 9 Homo sapiens 87.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515570&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 147100270 461601672 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082230 COc1ccc(Cl)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C29H31ClN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-22-10-9-21(34)16-36(22)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 DUJLETLIURKNQV-UHFFFAOYSA-N 515510 (3-Chloro-6-methoxypyridin-2-yl)(5-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 2)::US11098063, Example 26::US11098063, Example 69 Potassium channel subfamily K member 3 Human 2800 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515510&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462923 461601617 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082231 COc1ccc(Cl)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C29H31ClN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-22-10-9-21(34)16-36(22)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 DUJLETLIURKNQV-UHFFFAOYSA-N 515510 (3-Chloro-6-methoxypyridin-2-yl)(5-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 2)::US11098063, Example 26::US11098063, Example 69 Potassium channel subfamily K member 9 Homo sapiens 22.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515510&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462923 461601617 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082232 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CN2C(=O)c1ncoc1C1CC1 InChI=1S/C29H32N6O2/c1-18(2)19-4-6-20(7-5-19)25-24(34-13-3-12-30-29(34)32-25)16-33-14-23-11-10-22(33)15-35(23)28(36)26-27(21-8-9-21)37-17-31-26/h3-7,12-13,17-18,21-23H,8-11,14-16H2,1-2H3 JUFGAQSEOJOLNF-UHFFFAOYSA-N 515511 (5-Cyclopropyl-1,3-oxazol-4-yl)(5-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 2)::US11098063, Example 27::US11098063, Example 70 Potassium channel subfamily K member 3 Human 1900 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515511&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462916 461601618 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082233 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CN2C(=O)c1ncoc1C1CC1 InChI=1S/C29H32N6O2/c1-18(2)19-4-6-20(7-5-19)25-24(34-13-3-12-30-29(34)32-25)16-33-14-23-11-10-22(33)15-35(23)28(36)26-27(21-8-9-21)37-17-31-26/h3-7,12-13,17-18,21-23H,8-11,14-16H2,1-2H3 JUFGAQSEOJOLNF-UHFFFAOYSA-N 515511 (5-Cyclopropyl-1,3-oxazol-4-yl)(5-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,5-diazabicyclo[2.2.2]oct-2-yl)methanone (Enantiomer 2)::US11098063, Example 27::US11098063, Example 70 Potassium channel subfamily K member 9 Homo sapiens 20.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515511&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462916 461601618 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082234 COc1ccc(F)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C29H31FN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-22-10-9-21(34)16-36(22)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 ZWOWFMSAYBNPFB-UHFFFAOYSA-N 515573 US11098063, Example 71::US11098063, Example 72 Potassium channel subfamily K member 3 Human 14000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515573&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475156 461601673 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082235 COc1ccc(F)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C29H31FN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-22-10-9-21(34)16-36(22)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 ZWOWFMSAYBNPFB-UHFFFAOYSA-N 515573 US11098063, Example 71::US11098063, Example 72 Potassium channel subfamily K member 9 Homo sapiens 110 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515573&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475156 461601673 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082236 COc1ccc(F)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C29H31FN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-22-10-9-21(34)16-36(22)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 ZWOWFMSAYBNPFB-UHFFFAOYSA-N 515573 US11098063, Example 71::US11098063, Example 72 Potassium channel subfamily K member 3 Human 2100 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515573&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475156 461601673 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082237 COc1ccc(F)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C29H31FN6O2/c1-18(2)19-5-7-20(8-6-19)26-24(35-14-4-13-31-29(35)33-26)17-34-15-22-10-9-21(34)16-36(22)28(37)27-23(30)11-12-25(32-27)38-3/h4-8,11-14,18,21-22H,9-10,15-17H2,1-3H3 ZWOWFMSAYBNPFB-UHFFFAOYSA-N 515573 US11098063, Example 71::US11098063, Example 72 Potassium channel subfamily K member 9 Homo sapiens 29.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515573&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475156 461601673 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082238 COc1cccc(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C29H32N6O2/c1-19(2)20-8-10-21(11-9-20)27-25(34-15-5-14-30-29(34)32-27)18-33-16-23-13-12-22(33)17-35(23)28(36)24-6-4-7-26(31-24)37-3/h4-11,14-15,19,22-23H,12-13,16-18H2,1-3H3 ZFWOCSNMCZJTDA-UHFFFAOYSA-N 515575 US11098063, Example 73::US11098063, Example 74 Potassium channel subfamily K member 3 Human 9100 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515575&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 149495189 461601674 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082239 COc1cccc(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C29H32N6O2/c1-19(2)20-8-10-21(11-9-20)27-25(34-15-5-14-30-29(34)32-27)18-33-16-23-13-12-22(33)17-35(23)28(36)24-6-4-7-26(31-24)37-3/h4-11,14-15,19,22-23H,12-13,16-18H2,1-3H3 ZFWOCSNMCZJTDA-UHFFFAOYSA-N 515575 US11098063, Example 73::US11098063, Example 74 Potassium channel subfamily K member 9 Homo sapiens 81.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515575&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 149495189 461601674 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082240 COc1cccc(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C29H32N6O2/c1-19(2)20-8-10-21(11-9-20)27-25(34-15-5-14-30-29(34)32-27)18-33-16-23-13-12-22(33)17-35(23)28(36)24-6-4-7-26(31-24)37-3/h4-11,14-15,19,22-23H,12-13,16-18H2,1-3H3 ZFWOCSNMCZJTDA-UHFFFAOYSA-N 515575 US11098063, Example 73::US11098063, Example 74 Potassium channel subfamily K member 3 Human 3400 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515575&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 149495189 461601674 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082241 COc1cccc(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C29H32N6O2/c1-19(2)20-8-10-21(11-9-20)27-25(34-15-5-14-30-29(34)32-27)18-33-16-23-13-12-22(33)17-35(23)28(36)24-6-4-7-26(31-24)37-3/h4-11,14-15,19,22-23H,12-13,16-18H2,1-3H3 ZFWOCSNMCZJTDA-UHFFFAOYSA-N 515575 US11098063, Example 73::US11098063, Example 74 Potassium channel subfamily K member 9 Homo sapiens 61.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515575&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 149495189 461601674 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082242 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CN2C(=O)c1cccc(OC(F)F)n1 InChI=1S/C29H30F2N6O2/c1-18(2)19-7-9-20(10-8-19)26-24(36-14-4-13-32-29(36)34-26)17-35-15-22-12-11-21(35)16-37(22)27(38)23-5-3-6-25(33-23)39-28(30)31/h3-10,13-14,18,21-22,28H,11-12,15-17H2,1-2H3 PMDZYSBRJCKJBX-UHFFFAOYSA-N 515577 US11098063, Example 75::US11098063, Example 76 Potassium channel subfamily K member 3 Human 3800 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515577&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148932241 461601675 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082243 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CN2C(=O)c1cccc(OC(F)F)n1 InChI=1S/C29H30F2N6O2/c1-18(2)19-7-9-20(10-8-19)26-24(36-14-4-13-32-29(36)34-26)17-35-15-22-12-11-21(35)16-37(22)27(38)23-5-3-6-25(33-23)39-28(30)31/h3-10,13-14,18,21-22,28H,11-12,15-17H2,1-2H3 PMDZYSBRJCKJBX-UHFFFAOYSA-N 515577 US11098063, Example 75::US11098063, Example 76 Potassium channel subfamily K member 9 Homo sapiens 51.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515577&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148932241 461601675 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082244 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CN2C(=O)c1cccc(OC(F)F)n1 InChI=1S/C29H30F2N6O2/c1-18(2)19-7-9-20(10-8-19)26-24(36-14-4-13-32-29(36)34-26)17-35-15-22-12-11-21(35)16-37(22)27(38)23-5-3-6-25(33-23)39-28(30)31/h3-10,13-14,18,21-22,28H,11-12,15-17H2,1-2H3 PMDZYSBRJCKJBX-UHFFFAOYSA-N 515577 US11098063, Example 75::US11098063, Example 76 Potassium channel subfamily K member 3 Human 13000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515577&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148932241 461601675 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082245 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CN2C(=O)c1cccc(OC(F)F)n1 InChI=1S/C29H30F2N6O2/c1-18(2)19-7-9-20(10-8-19)26-24(36-14-4-13-32-29(36)34-26)17-35-15-22-12-11-21(35)16-37(22)27(38)23-5-3-6-25(33-23)39-28(30)31/h3-10,13-14,18,21-22,28H,11-12,15-17H2,1-2H3 PMDZYSBRJCKJBX-UHFFFAOYSA-N 515577 US11098063, Example 75::US11098063, Example 76 Potassium channel subfamily K member 9 Homo sapiens 56.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515577&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148932241 461601675 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082246 COc1ccc(C)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H34N6O2/c1-19(2)21-7-9-22(10-8-21)28-25(35-15-5-14-31-30(35)33-28)18-34-16-24-12-11-23(34)17-36(24)29(37)27-20(3)6-13-26(32-27)38-4/h5-10,13-15,19,23-24H,11-12,16-18H2,1-4H3 DMKQQNXPDITBNA-UHFFFAOYSA-N 515579 US11098063, Example 77::US11098063, Example 78 Potassium channel subfamily K member 3 Human 720 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515579&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 147388674 461601676 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082247 COc1ccc(C)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H34N6O2/c1-19(2)21-7-9-22(10-8-21)28-25(35-15-5-14-31-30(35)33-28)18-34-16-24-12-11-23(34)17-36(24)29(37)27-20(3)6-13-26(32-27)38-4/h5-10,13-15,19,23-24H,11-12,16-18H2,1-4H3 DMKQQNXPDITBNA-UHFFFAOYSA-N 515579 US11098063, Example 77::US11098063, Example 78 Potassium channel subfamily K member 9 Homo sapiens 4.90 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515579&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 147388674 461601676 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082248 COc1ccc(C)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H34N6O2/c1-19(2)21-7-9-22(10-8-21)28-25(35-15-5-14-31-30(35)33-28)18-34-16-24-12-11-23(34)17-36(24)29(37)27-20(3)6-13-26(32-27)38-4/h5-10,13-15,19,23-24H,11-12,16-18H2,1-4H3 DMKQQNXPDITBNA-UHFFFAOYSA-N 515579 US11098063, Example 77::US11098063, Example 78 Potassium channel subfamily K member 3 Human 3800 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515579&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 147388674 461601676 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082249 COc1ccc(C)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H34N6O2/c1-19(2)21-7-9-22(10-8-21)28-25(35-15-5-14-31-30(35)33-28)18-34-16-24-12-11-23(34)17-36(24)29(37)27-20(3)6-13-26(32-27)38-4/h5-10,13-15,19,23-24H,11-12,16-18H2,1-4H3 DMKQQNXPDITBNA-UHFFFAOYSA-N 515579 US11098063, Example 77::US11098063, Example 78 Potassium channel subfamily K member 9 Homo sapiens 24.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515579&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 147388674 461601676 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082250 COc1ccc(F)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Br)cc1 InChI=1S/C26H24BrFN6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-14-18-7-8-19(34)13-32(18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 CPJLWFMBUNYSCZ-UHFFFAOYSA-N 515581 US11098063, Example 81 Potassium channel subfamily K member 3 Human 820 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515581&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 147265410 461601677 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082251 COc1ccc(F)c(n1)C(=O)N1CC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Br)cc1 InChI=1S/C26H24BrFN6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-14-18-7-8-19(34)13-32(18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 CPJLWFMBUNYSCZ-UHFFFAOYSA-N 515581 US11098063, Example 81 Potassium channel subfamily K member 9 Homo sapiens 21.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515581&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 147265410 461601677 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082252 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Br)cc1)C2 InChI=1S/C26H24BrFN6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-18-7-8-19(34)14-32(13-18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 MMISRIBEVUTFLD-UHFFFAOYSA-N 515582 US11098063, Example 82 Potassium channel subfamily K member 3 Human 670 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515582&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148510182 461601678 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082253 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Br)cc1)C2 InChI=1S/C26H24BrFN6O2/c1-36-22-10-9-20(28)24(30-22)25(35)34-18-7-8-19(34)14-32(13-18)15-21-23(16-3-5-17(27)6-4-16)31-26-29-11-2-12-33(21)26/h2-6,9-12,18-19H,7-8,13-15H2,1H3 MMISRIBEVUTFLD-UHFFFAOYSA-N 515582 US11098063, Example 82 Potassium channel subfamily K member 9 Homo sapiens 37.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515582&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148510182 461601678 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082254 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Br)cc1)C2 InChI=1S/C26H23BrFN5O/c27-18-8-6-17(7-9-18)24-23(32-13-3-12-29-26(32)30-24)16-31-14-19-10-11-20(15-31)33(19)25(34)21-4-1-2-5-22(21)28/h1-9,12-13,19-20H,10-11,14-16H2 TYXZNDSVNPNYAZ-UHFFFAOYSA-N 515583 US11098063, Example 83 Potassium channel subfamily K member 3 Human 250 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515583&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 152868493 461601679 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082255 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Br)cc1)C2 InChI=1S/C26H23BrFN5O/c27-18-8-6-17(7-9-18)24-23(32-13-3-12-29-26(32)30-24)16-31-14-19-10-11-20(15-31)33(19)25(34)21-4-1-2-5-22(21)28/h1-9,12-13,19-20H,10-11,14-16H2 TYXZNDSVNPNYAZ-UHFFFAOYSA-N 515583 US11098063, Example 83 Potassium channel subfamily K member 9 Homo sapiens 14.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515583&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 152868493 461601679 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082256 Brc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)C1CCCC1 InChI=1S/C25H28BrN5O/c26-19-8-6-17(7-9-19)23-22(30-13-3-12-27-25(30)28-23)16-29-14-20-10-11-21(15-29)31(20)24(32)18-4-1-2-5-18/h3,6-9,12-13,18,20-21H,1-2,4-5,10-11,14-16H2 LMDDKRAYDNRKPL-UHFFFAOYSA-N 515584 US11098063, Example 84 Potassium channel subfamily K member 3 Human 93.0 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515584&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148370076 461601680 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082257 Brc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)C1CCCC1 InChI=1S/C25H28BrN5O/c26-19-8-6-17(7-9-19)23-22(30-13-3-12-27-25(30)28-23)16-29-14-20-10-11-21(15-29)31(20)24(32)18-4-1-2-5-18/h3,6-9,12-13,18,20-21H,1-2,4-5,10-11,14-16H2 LMDDKRAYDNRKPL-UHFFFAOYSA-N 515584 US11098063, Example 84 Potassium channel subfamily K member 9 Homo sapiens 4.60 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515584&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148370076 461601680 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082258 Fc1ccc(NC(=O)N2C3CCC2CN(Cc2c(nc4ncccn24)-c2ccc(Cl)cc2)C3)c(F)c1 InChI=1S/C26H23ClF2N6O/c27-17-4-2-16(3-5-17)24-23(34-11-1-10-30-25(34)32-24)15-33-13-19-7-8-20(14-33)35(19)26(36)31-22-9-6-18(28)12-21(22)29/h1-6,9-12,19-20H,7-8,13-15H2,(H,31,36) DUTOYTKLDRWBEK-UHFFFAOYSA-N 515585 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-N-(2,4-difluorophenyl)-3,8-diazabicyclo[3.2.1]octane-8-carboxamide::US11098063, Example 85 Potassium channel subfamily K member 3 Human 30000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515585&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462994 461601681 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082259 Fc1ccc(NC(=O)N2C3CCC2CN(Cc2c(nc4ncccn24)-c2ccc(Cl)cc2)C3)c(F)c1 InChI=1S/C26H23ClF2N6O/c27-17-4-2-16(3-5-17)24-23(34-11-1-10-30-25(34)32-24)15-33-13-19-7-8-20(14-33)35(19)26(36)31-22-9-6-18(28)12-21(22)29/h1-6,9-12,19-20H,7-8,13-15H2,(H,31,36) DUTOYTKLDRWBEK-UHFFFAOYSA-N 515585 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-N-(2,4-difluorophenyl)-3,8-diazabicyclo[3.2.1]octane-8-carboxamide::US11098063, Example 85 Potassium channel subfamily K member 9 Homo sapiens 1000 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515585&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462994 461601681 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082260 CC(C)NC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C23H27ClN6O/c1-15(2)26-23(31)30-18-8-9-19(30)13-28(12-18)14-20-21(16-4-6-17(24)7-5-16)27-22-25-10-3-11-29(20)22/h3-7,10-11,15,18-19H,8-9,12-14H2,1-2H3,(H,26,31) VORAULAKGPJQQQ-UHFFFAOYSA-N 515586 US11098063, Example 86 Potassium channel subfamily K member 3 Human 7700 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515586&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153088414 461601682 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082261 CC(C)NC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C23H27ClN6O/c1-15(2)26-23(31)30-18-8-9-19(30)13-28(12-18)14-20-21(16-4-6-17(24)7-5-16)27-22-25-10-3-11-29(20)22/h3-7,10-11,15,18-19H,8-9,12-14H2,1-2H3,(H,26,31) VORAULAKGPJQQQ-UHFFFAOYSA-N 515586 US11098063, Example 86 Potassium channel subfamily K member 9 Homo sapiens 430 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515586&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153088414 461601682 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082262 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)Nc1cccc(Cl)c1 InChI=1S/C26H24Cl2N6O/c27-18-7-5-17(6-8-18)24-23(33-12-2-11-29-25(33)31-24)16-32-14-21-9-10-22(15-32)34(21)26(35)30-20-4-1-3-19(28)13-20/h1-8,11-13,21-22H,9-10,14-16H2,(H,30,35) JBRWTVNRVMWFMX-UHFFFAOYSA-N 515587 US11098063, Example 89 Potassium channel subfamily K member 3 Human 30000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515587&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 155717789 461601683 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082263 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)Nc1cccc(Cl)c1 InChI=1S/C26H24Cl2N6O/c27-18-7-5-17(6-8-18)24-23(33-12-2-11-29-25(33)31-24)16-32-14-21-9-10-22(15-32)34(21)26(35)30-20-4-1-3-19(28)13-20/h1-8,11-13,21-22H,9-10,14-16H2,(H,30,35) JBRWTVNRVMWFMX-UHFFFAOYSA-N 515587 US11098063, Example 89 Potassium channel subfamily K member 9 Homo sapiens 850 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515587&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 155717789 461601683 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082264 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)Nc1c(Cl)cccc1Cl InChI=1S/C26H23Cl3N6O/c27-17-7-5-16(6-8-17)23-22(34-12-2-11-30-25(34)31-23)15-33-13-18-9-10-19(14-33)35(18)26(36)32-24-20(28)3-1-4-21(24)29/h1-8,11-12,18-19H,9-10,13-15H2,(H,32,36) LFWLSFPDWOFNOW-UHFFFAOYSA-N 515588 US11098063, Example 91 Potassium channel subfamily K member 3 Human 20000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515588&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 155270962 461601684 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082265 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)Nc1c(Cl)cccc1Cl InChI=1S/C26H23Cl3N6O/c27-17-7-5-16(6-8-17)23-22(34-12-2-11-30-25(34)31-23)15-33-13-18-9-10-19(14-33)35(18)26(36)32-24-20(28)3-1-4-21(24)29/h1-8,11-12,18-19H,9-10,13-15H2,(H,32,36) LFWLSFPDWOFNOW-UHFFFAOYSA-N 515588 US11098063, Example 91 Potassium channel subfamily K member 9 Homo sapiens 410 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515588&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 155270962 461601684 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082266 Cc1cccc(C)c1NC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C28H29ClN6O/c1-18-5-3-6-19(2)25(18)32-28(36)35-22-11-12-23(35)16-33(15-22)17-24-26(20-7-9-21(29)10-8-20)31-27-30-13-4-14-34(24)27/h3-10,13-14,22-23H,11-12,15-17H2,1-2H3,(H,32,36) IRNHBYUVDATQPS-UHFFFAOYSA-N 515589 US11098063, Example 92 Potassium channel subfamily K member 3 Human 15000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515589 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515589&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 147972000 461601685 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082267 Cc1cccc(C)c1NC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C28H29ClN6O/c1-18-5-3-6-19(2)25(18)32-28(36)35-22-11-12-23(35)16-33(15-22)17-24-26(20-7-9-21(29)10-8-20)31-27-30-13-4-14-34(24)27/h3-10,13-14,22-23H,11-12,15-17H2,1-2H3,(H,32,36) IRNHBYUVDATQPS-UHFFFAOYSA-N 515589 US11098063, Example 92 Potassium channel subfamily K member 9 Homo sapiens 270 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515589 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515589&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 147972000 461601685 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082268 Fc1ccccc1NC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H24ClFN6O/c27-18-8-6-17(7-9-18)24-23(33-13-3-12-29-25(33)31-24)16-32-14-19-10-11-20(15-32)34(19)26(35)30-22-5-2-1-4-21(22)28/h1-9,12-13,19-20H,10-11,14-16H2,(H,30,35) ODHLGQSQWRLWSC-UHFFFAOYSA-N 515590 US11098063, Example 93 Potassium channel subfamily K member 3 Human 12000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515590&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148743469 461601686 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082269 Fc1ccccc1NC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H24ClFN6O/c27-18-8-6-17(7-9-18)24-23(33-13-3-12-29-25(33)31-24)16-32-14-19-10-11-20(15-32)34(19)26(35)30-22-5-2-1-4-21(22)28/h1-9,12-13,19-20H,10-11,14-16H2,(H,30,35) ODHLGQSQWRLWSC-UHFFFAOYSA-N 515590 US11098063, Example 93 Potassium channel subfamily K member 9 Homo sapiens 260 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515590&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148743469 461601686 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082270 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)Nc1cccc(Cl)c1Cl InChI=1S/C26H23Cl3N6O/c27-17-7-5-16(6-8-17)24-22(34-12-2-11-30-25(34)32-24)15-33-13-18-9-10-19(14-33)35(18)26(36)31-21-4-1-3-20(28)23(21)29/h1-8,11-12,18-19H,9-10,13-15H2,(H,31,36) JMDJOUCDAVZNCX-UHFFFAOYSA-N 515591 US11098063, Example 94 Potassium channel subfamily K member 3 Human 30000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515591&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 155270978 461601687 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082271 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)Nc1cccc(Cl)c1Cl InChI=1S/C26H23Cl3N6O/c27-17-7-5-16(6-8-17)24-22(34-12-2-11-30-25(34)32-24)15-33-13-18-9-10-19(14-33)35(18)26(36)31-21-4-1-3-20(28)23(21)29/h1-8,11-12,18-19H,9-10,13-15H2,(H,31,36) JMDJOUCDAVZNCX-UHFFFAOYSA-N 515591 US11098063, Example 94 Potassium channel subfamily K member 9 Homo sapiens 160 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515591&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 155270978 461601687 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082272 CCc1ccccc1NC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C28H29ClN6O/c1-2-19-6-3-4-7-24(19)31-28(36)35-22-12-13-23(35)17-33(16-22)18-25-26(20-8-10-21(29)11-9-20)32-27-30-14-5-15-34(25)27/h3-11,14-15,22-23H,2,12-13,16-18H2,1H3,(H,31,36) DWODJHNCNCAQBT-UHFFFAOYSA-N 515592 US11098063, Example 95 Potassium channel subfamily K member 3 Human 3000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515592&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 155717797 461601688 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082273 CCc1ccccc1NC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C28H29ClN6O/c1-2-19-6-3-4-7-24(19)31-28(36)35-22-12-13-23(35)17-33(16-22)18-25-26(20-8-10-21(29)11-9-20)32-27-30-14-5-15-34(25)27/h3-11,14-15,22-23H,2,12-13,16-18H2,1H3,(H,31,36) DWODJHNCNCAQBT-UHFFFAOYSA-N 515592 US11098063, Example 95 Potassium channel subfamily K member 9 Homo sapiens 41.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515592&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 155717797 461601688 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082274 FC(F)(F)c1ccc(Cl)c(NC(=O)N2C3CCC2CN(Cc2c(nc4ncccn24)-c2ccc(Cl)cc2)C3)c1 InChI=1S/C27H23Cl2F3N6O/c28-18-5-2-16(3-6-18)24-23(37-11-1-10-33-25(37)35-24)15-36-13-19-7-8-20(14-36)38(19)26(39)34-22-12-17(27(30,31)32)4-9-21(22)29/h1-6,9-12,19-20H,7-8,13-15H2,(H,34,39) YQDWJBKSUDKZGC-UHFFFAOYSA-N 515593 US11098063, Example 97 Potassium channel subfamily K member 3 Human 31000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515593 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515593&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 149405230 461601689 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082275 FC(F)(F)c1ccc(Cl)c(NC(=O)N2C3CCC2CN(Cc2c(nc4ncccn24)-c2ccc(Cl)cc2)C3)c1 InChI=1S/C27H23Cl2F3N6O/c28-18-5-2-16(3-6-18)24-23(37-11-1-10-33-25(37)35-24)15-36-13-19-7-8-20(14-36)38(19)26(39)34-22-12-17(27(30,31)32)4-9-21(22)29/h1-6,9-12,19-20H,7-8,13-15H2,(H,34,39) YQDWJBKSUDKZGC-UHFFFAOYSA-N 515593 US11098063, Example 97 Potassium channel subfamily K member 9 Homo sapiens 450 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515593 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515593&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 149405230 461601689 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082276 CCc1cccc(C)c1NC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C29H31ClN6O/c1-3-20-7-4-6-19(2)26(20)33-29(37)36-23-12-13-24(36)17-34(16-23)18-25-27(21-8-10-22(30)11-9-21)32-28-31-14-5-15-35(25)28/h4-11,14-15,23-24H,3,12-13,16-18H2,1-2H3,(H,33,37) LAIBKAMSVGUYSB-UHFFFAOYSA-N 515594 US11098063, Example 98 Potassium channel subfamily K member 3 Human 9000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515594 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515594&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148307093 461601690 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082277 CCc1cccc(C)c1NC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C29H31ClN6O/c1-3-20-7-4-6-19(2)26(20)33-29(37)36-23-12-13-24(36)17-34(16-23)18-25-27(21-8-10-22(30)11-9-21)32-28-31-14-5-15-35(25)28/h4-11,14-15,23-24H,3,12-13,16-18H2,1-2H3,(H,33,37) LAIBKAMSVGUYSB-UHFFFAOYSA-N 515594 US11098063, Example 98 Potassium channel subfamily K member 9 Homo sapiens 160 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515594 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515594&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148307093 461601690 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082278 Cc1ccc(C)c(NC(=O)N2C3CCC2CN(Cc2c(nc4ncccn24)-c2ccc(Cl)cc2)C3)c1 InChI=1S/C28H29ClN6O/c1-18-4-5-19(2)24(14-18)31-28(36)35-22-10-11-23(35)16-33(15-22)17-25-26(20-6-8-21(29)9-7-20)32-27-30-12-3-13-34(25)27/h3-9,12-14,22-23H,10-11,15-17H2,1-2H3,(H,31,36) UHUDMLGYHRTUGD-UHFFFAOYSA-N 515595 US11098063, Example 99 Potassium channel subfamily K member 3 Human 30000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515595&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 152914148 461601691 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082279 Cc1ccc(C)c(NC(=O)N2C3CCC2CN(Cc2c(nc4ncccn24)-c2ccc(Cl)cc2)C3)c1 InChI=1S/C28H29ClN6O/c1-18-4-5-19(2)24(14-18)31-28(36)35-22-10-11-23(35)16-33(15-22)17-25-26(20-6-8-21(29)9-7-20)32-27-30-12-3-13-34(25)27/h3-9,12-14,22-23H,10-11,15-17H2,1-2H3,(H,31,36) UHUDMLGYHRTUGD-UHFFFAOYSA-N 515595 US11098063, Example 99 Potassium channel subfamily K member 9 Homo sapiens 750 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515595&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 152914148 461601691 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082280 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)NC1CCCCC1 InChI=1S/C26H31ClN6O/c27-19-9-7-18(8-10-19)24-23(32-14-4-13-28-25(32)30-24)17-31-15-21-11-12-22(16-31)33(21)26(34)29-20-5-2-1-3-6-20/h4,7-10,13-14,20-22H,1-3,5-6,11-12,15-17H2,(H,29,34) MPAMLEOYAPOXGL-UHFFFAOYSA-N 515596 US11098063, Example 100 Potassium channel subfamily K member 3 Human 19000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515596&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 155717795 461601692 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082281 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)NC1CCCCC1 InChI=1S/C26H31ClN6O/c27-19-9-7-18(8-10-19)24-23(32-14-4-13-28-25(32)30-24)17-31-15-21-11-12-22(16-31)33(21)26(34)29-20-5-2-1-3-6-20/h4,7-10,13-14,20-22H,1-3,5-6,11-12,15-17H2,(H,29,34) MPAMLEOYAPOXGL-UHFFFAOYSA-N 515596 US11098063, Example 100 Potassium channel subfamily K member 9 Homo sapiens 630 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515596&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 155717795 461601692 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082282 CC(C)CNC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H29ClN6O/c1-16(2)12-27-24(32)31-19-8-9-20(31)14-29(13-19)15-21-22(17-4-6-18(25)7-5-17)28-23-26-10-3-11-30(21)23/h3-7,10-11,16,19-20H,8-9,12-15H2,1-2H3,(H,27,32) FIJNMKAKNRNHJU-UHFFFAOYSA-N 515597 US11098063, Example 101 Potassium channel subfamily K member 3 Human 19000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515597 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515597&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 155270943 461601693 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082283 CC(C)CNC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H29ClN6O/c1-16(2)12-27-24(32)31-19-8-9-20(31)14-29(13-19)15-21-22(17-4-6-18(25)7-5-17)28-23-26-10-3-11-30(21)23/h3-7,10-11,16,19-20H,8-9,12-15H2,1-2H3,(H,27,32) FIJNMKAKNRNHJU-UHFFFAOYSA-N 515597 US11098063, Example 101 Potassium channel subfamily K member 9 Homo sapiens 510 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515597 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515597&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 155270943 461601693 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082284 FC(F)(F)Sc1ccc(NC(=O)N2C3CCC2CN(Cc2c(nc4ncccn24)-c2ccc(Cl)cc2)C3)cc1 InChI=1S/C27H24ClF3N6OS/c28-18-4-2-17(3-5-18)24-23(36-13-1-12-32-25(36)34-24)16-35-14-20-8-9-21(15-35)37(20)26(38)33-19-6-10-22(11-7-19)39-27(29,30)31/h1-7,10-13,20-21H,8-9,14-16H2,(H,33,38) JOJLKTHHOOHDAD-UHFFFAOYSA-N 515598 US11098063, Example 103 Potassium channel subfamily K member 3 Human 30000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515598&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148093786 461601694 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082285 FC(F)(F)Sc1ccc(NC(=O)N2C3CCC2CN(Cc2c(nc4ncccn24)-c2ccc(Cl)cc2)C3)cc1 InChI=1S/C27H24ClF3N6OS/c28-18-4-2-17(3-5-18)24-23(36-13-1-12-32-25(36)34-24)16-35-14-20-8-9-21(15-35)37(20)26(38)33-19-6-10-22(11-7-19)39-27(29,30)31/h1-7,10-13,20-21H,8-9,14-16H2,(H,33,38) JOJLKTHHOOHDAD-UHFFFAOYSA-N 515598 US11098063, Example 103 Potassium channel subfamily K member 9 Homo sapiens 690 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515598&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148093786 461601694 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082286 Fc1cccc(NC(=O)N2C3CCC2CN(Cc2c(nc4ncccn24)-c2ccc(Cl)cc2)C3)c1 InChI=1S/C26H24ClFN6O/c27-18-7-5-17(6-8-18)24-23(33-12-2-11-29-25(33)31-24)16-32-14-21-9-10-22(15-32)34(21)26(35)30-20-4-1-3-19(28)13-20/h1-8,11-13,21-22H,9-10,14-16H2,(H,30,35) LRWFAUKRGSBMFM-UHFFFAOYSA-N 515599 US11098063, Example 104 Potassium channel subfamily K member 3 Human 19000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515599&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148401180 461601695 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082287 Fc1cccc(NC(=O)N2C3CCC2CN(Cc2c(nc4ncccn24)-c2ccc(Cl)cc2)C3)c1 InChI=1S/C26H24ClFN6O/c27-18-7-5-17(6-8-18)24-23(33-12-2-11-29-25(33)31-24)16-32-14-21-9-10-22(15-32)34(21)26(35)30-20-4-1-3-19(28)13-20/h1-8,11-13,21-22H,9-10,14-16H2,(H,30,35) LRWFAUKRGSBMFM-UHFFFAOYSA-N 515599 US11098063, Example 104 Potassium channel subfamily K member 9 Homo sapiens 460 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515599&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148401180 461601695 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082288 FC(F)(F)c1cc(Cl)ccc1NC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C27H23Cl2F3N6O/c28-17-4-2-16(3-5-17)24-23(37-11-1-10-33-25(37)35-24)15-36-13-19-7-8-20(14-36)38(19)26(39)34-22-9-6-18(29)12-21(22)27(30,31)32/h1-6,9-12,19-20H,7-8,13-15H2,(H,34,39) NMGXFYKAQLYADW-UHFFFAOYSA-N 515600 US11098063, Example 106 Potassium channel subfamily K member 3 Human 30000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515600&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 155717794 461601696 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082289 FC(F)(F)c1cc(Cl)ccc1NC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C27H23Cl2F3N6O/c28-17-4-2-16(3-5-17)24-23(37-11-1-10-33-25(37)35-24)15-36-13-19-7-8-20(14-36)38(19)26(39)34-22-9-6-18(29)12-21(22)27(30,31)32/h1-6,9-12,19-20H,7-8,13-15H2,(H,34,39) NMGXFYKAQLYADW-UHFFFAOYSA-N 515600 US11098063, Example 106 Potassium channel subfamily K member 9 Homo sapiens 89.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515600&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 155717794 461601696 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082290 Cc1ccccc1CNC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C28H29ClN6O/c1-19-5-2-3-6-21(19)15-31-28(36)35-23-11-12-24(35)17-33(16-23)18-25-26(20-7-9-22(29)10-8-20)32-27-30-13-4-14-34(25)27/h2-10,13-14,23-24H,11-12,15-18H2,1H3,(H,31,36) QCNVPQBOCBGFRO-UHFFFAOYSA-N 515601 US11098063, Example 107 Potassium channel subfamily K member 3 Human 30000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515601 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515601&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 155717790 461601697 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082291 Cc1ccccc1CNC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C28H29ClN6O/c1-19-5-2-3-6-21(19)15-31-28(36)35-23-11-12-24(35)17-33(16-23)18-25-26(20-7-9-22(29)10-8-20)32-27-30-13-4-14-34(25)27/h2-10,13-14,23-24H,11-12,15-18H2,1H3,(H,31,36) QCNVPQBOCBGFRO-UHFFFAOYSA-N 515601 US11098063, Example 107 Potassium channel subfamily K member 9 Homo sapiens 750 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515601 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515601&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 155717790 461601697 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082292 CN(C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2)c1ccccc1 InChI=1S/C27H27ClN6O/c1-31(21-6-3-2-4-7-21)27(35)34-22-12-13-23(34)17-32(16-22)18-24-25(19-8-10-20(28)11-9-19)30-26-29-14-5-15-33(24)26/h2-11,14-15,22-23H,12-13,16-18H2,1H3 NCHLYNWHULNYGB-UHFFFAOYSA-N 515602 US11098063, Example 108 Potassium channel subfamily K member 3 Human 7000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515602&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148599886 461601698 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082293 CN(C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2)c1ccccc1 InChI=1S/C27H27ClN6O/c1-31(21-6-3-2-4-7-21)27(35)34-22-12-13-23(34)17-32(16-22)18-24-25(19-8-10-20(28)11-9-19)30-26-29-14-5-15-33(24)26/h2-11,14-15,22-23H,12-13,16-18H2,1H3 NCHLYNWHULNYGB-UHFFFAOYSA-N 515602 US11098063, Example 108 Potassium channel subfamily K member 9 Homo sapiens 90.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515602&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148599886 461601698 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082294 CCN(CC)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H29ClN6O/c1-3-29(4-2)24(32)31-19-10-11-20(31)15-28(14-19)16-21-22(17-6-8-18(25)9-7-17)27-23-26-12-5-13-30(21)23/h5-9,12-13,19-20H,3-4,10-11,14-16H2,1-2H3 BGSQOLDZDTUGQJ-UHFFFAOYSA-N 515603 US11098063, Example 109 Potassium channel subfamily K member 3 Human 24.0 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515603&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475158 461601699 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082295 CCN(CC)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H29ClN6O/c1-3-29(4-2)24(32)31-19-10-11-20(31)15-28(14-19)16-21-22(17-6-8-18(25)9-7-17)27-23-26-12-5-13-30(21)23/h5-9,12-13,19-20H,3-4,10-11,14-16H2,1-2H3 BGSQOLDZDTUGQJ-UHFFFAOYSA-N 515603 US11098063, Example 109 Potassium channel subfamily K member 9 Homo sapiens 1.50 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515603&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475158 461601699 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082296 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)N1CCOCC1 InChI=1S/C24H27ClN6O2/c25-18-4-2-17(3-5-18)22-21(30-9-1-8-26-23(30)27-22)16-28-14-19-6-7-20(15-28)31(19)24(32)29-10-12-33-13-11-29/h1-5,8-9,19-20H,6-7,10-16H2 RIFHNUOQSJHRHK-UHFFFAOYSA-N 515604 US11098063, Example 110 Potassium channel subfamily K member 3 Human 13000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515604&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146732277 461601700 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082297 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)N1CCOCC1 InChI=1S/C24H27ClN6O2/c25-18-4-2-17(3-5-18)22-21(30-9-1-8-26-23(30)27-22)16-28-14-19-6-7-20(15-28)31(19)24(32)29-10-12-33-13-11-29/h1-5,8-9,19-20H,6-7,10-16H2 RIFHNUOQSJHRHK-UHFFFAOYSA-N 515604 US11098063, Example 110 Potassium channel subfamily K member 9 Homo sapiens 230 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515604&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146732277 461601700 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082298 CC(C)N(C(C)C)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H33ClN6O/c1-17(2)32(18(3)4)26(34)33-21-10-11-22(33)15-30(14-21)16-23-24(19-6-8-20(27)9-7-19)29-25-28-12-5-13-31(23)25/h5-9,12-13,17-18,21-22H,10-11,14-16H2,1-4H3 YTZZHUVKSATAKZ-UHFFFAOYSA-N 515605 US11098063, Example 111 Potassium channel subfamily K member 3 Human 6300 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515605 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515605&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475157 461601701 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082299 CC(C)N(C(C)C)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C26H33ClN6O/c1-17(2)32(18(3)4)26(34)33-21-10-11-22(33)15-30(14-21)16-23-24(19-6-8-20(27)9-7-19)29-25-28-12-5-13-31(23)25/h5-9,12-13,17-18,21-22H,10-11,14-16H2,1-4H3 YTZZHUVKSATAKZ-UHFFFAOYSA-N 515605 US11098063, Example 111 Potassium channel subfamily K member 9 Homo sapiens 290 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515605 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515605&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475157 461601701 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082300 CCN(C1CCCCC1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C28H35ClN6O/c1-2-33(22-7-4-3-5-8-22)28(36)35-23-13-14-24(35)18-32(17-23)19-25-26(20-9-11-21(29)12-10-20)31-27-30-15-6-16-34(25)27/h6,9-12,15-16,22-24H,2-5,7-8,13-14,17-19H2,1H3 JLVRNKVRXZELNP-UHFFFAOYSA-N 515606 US11098063, Example 112 Potassium channel subfamily K member 3 Human 15000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515606&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148080335 461601702 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082301 CCN(C1CCCCC1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C28H35ClN6O/c1-2-33(22-7-4-3-5-8-22)28(36)35-23-13-14-24(35)18-32(17-23)19-25-26(20-9-11-21(29)12-10-20)31-27-30-15-6-16-34(25)27/h6,9-12,15-16,22-24H,2-5,7-8,13-14,17-19H2,1H3 JLVRNKVRXZELNP-UHFFFAOYSA-N 515606 US11098063, Example 112 Potassium channel subfamily K member 9 Homo sapiens 130 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515606&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148080335 461601702 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082302 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)N1CCCC1 InChI=1S/C24H27ClN6O/c25-18-6-4-17(5-7-18)22-21(30-13-3-10-26-23(30)27-22)16-28-14-19-8-9-20(15-28)31(19)24(32)29-11-1-2-12-29/h3-7,10,13,19-20H,1-2,8-9,11-12,14-16H2 RDQMKIWPWLPVGH-UHFFFAOYSA-N 515607 US11098063, Example 113 Potassium channel subfamily K member 3 Human 1100 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515607&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 149133695 461601703 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082303 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)N1CCCC1 InChI=1S/C24H27ClN6O/c25-18-6-4-17(5-7-18)22-21(30-13-3-10-26-23(30)27-22)16-28-14-19-8-9-20(15-28)31(19)24(32)29-11-1-2-12-29/h3-7,10,13,19-20H,1-2,8-9,11-12,14-16H2 RDQMKIWPWLPVGH-UHFFFAOYSA-N 515607 US11098063, Example 113 Potassium channel subfamily K member 9 Homo sapiens 62.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515607&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 149133695 461601703 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082304 CCN(C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2)c1ccccc1 InChI=1S/C28H29ClN6O/c1-2-33(22-7-4-3-5-8-22)28(36)35-23-13-14-24(35)18-32(17-23)19-25-26(20-9-11-21(29)12-10-20)31-27-30-15-6-16-34(25)27/h3-12,15-16,23-24H,2,13-14,17-19H2,1H3 HCGUDJNCVDKJBS-UHFFFAOYSA-N 515608 US11098063, Example 114 Potassium channel subfamily K member 3 Human 6700 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515608&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 147751433 461601704 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082305 CCN(C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2)c1ccccc1 InChI=1S/C28H29ClN6O/c1-2-33(22-7-4-3-5-8-22)28(36)35-23-13-14-24(35)18-32(17-23)19-25-26(20-9-11-21(29)12-10-20)31-27-30-15-6-16-34(25)27/h3-12,15-16,23-24H,2,13-14,17-19H2,1H3 HCGUDJNCVDKJBS-UHFFFAOYSA-N 515608 US11098063, Example 114 Potassium channel subfamily K member 9 Homo sapiens 140 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515608&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 147751433 461601704 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082306 CC(C)N(C)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H29ClN6O/c1-16(2)28(3)24(32)31-19-9-10-20(31)14-29(13-19)15-21-22(17-5-7-18(25)8-6-17)27-23-26-11-4-12-30(21)23/h4-8,11-12,16,19-20H,9-10,13-15H2,1-3H3 ABCBAFNDQVXVCQ-UHFFFAOYSA-N 515609 US11098063, Example 115 Potassium channel subfamily K member 3 Human 7400 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515609&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146909832 461601705 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082307 CC(C)N(C)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C24H29ClN6O/c1-16(2)28(3)24(32)31-19-9-10-20(31)14-29(13-19)15-21-22(17-5-7-18(25)8-6-17)27-23-26-11-4-12-30(21)23/h4-8,11-12,16,19-20H,9-10,13-15H2,1-3H3 ABCBAFNDQVXVCQ-UHFFFAOYSA-N 515609 US11098063, Example 115 Potassium channel subfamily K member 9 Homo sapiens 330 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515609&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146909832 461601705 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082308 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)N1CCCCC1 InChI=1S/C25H29ClN6O/c26-19-7-5-18(6-8-19)23-22(31-14-4-11-27-24(31)28-23)17-29-15-20-9-10-21(16-29)32(20)25(33)30-12-2-1-3-13-30/h4-8,11,14,20-21H,1-3,9-10,12-13,15-17H2 NZEKNCVGMPWXBU-UHFFFAOYSA-N 515610 US11098063, Example 116 Potassium channel subfamily K member 3 Human 2700 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515610&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148721558 461601706 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082309 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)N1CCCCC1 InChI=1S/C25H29ClN6O/c26-19-7-5-18(6-8-19)23-22(31-14-4-11-27-24(31)28-23)17-29-15-20-9-10-21(16-29)32(20)25(33)30-12-2-1-3-13-30/h4-8,11,14,20-21H,1-3,9-10,12-13,15-17H2 NZEKNCVGMPWXBU-UHFFFAOYSA-N 515610 US11098063, Example 116 Potassium channel subfamily K member 9 Homo sapiens 65.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515610&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148721558 461601706 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082310 CC(C)N(C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2)c1ccc(Cl)cc1 InChI=1S/C29H30Cl2N6O/c1-19(2)36(23-10-8-22(31)9-11-23)29(38)37-24-12-13-25(37)17-34(16-24)18-26-27(20-4-6-21(30)7-5-20)33-28-32-14-3-15-35(26)28/h3-11,14-15,19,24-25H,12-13,16-18H2,1-2H3 JMCRISPMPHLCGV-UHFFFAOYSA-N 515611 US11098063, Example 118 Potassium channel subfamily K member 3 Human 19000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515611 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515611&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475160 461601707 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082311 CC(C)N(C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2)c1ccc(Cl)cc1 InChI=1S/C29H30Cl2N6O/c1-19(2)36(23-10-8-22(31)9-11-23)29(38)37-24-12-13-25(37)17-34(16-24)18-26-27(20-4-6-21(30)7-5-20)33-28-32-14-3-15-35(26)28/h3-11,14-15,19,24-25H,12-13,16-18H2,1-2H3 JMCRISPMPHLCGV-UHFFFAOYSA-N 515611 US11098063, Example 118 Potassium channel subfamily K member 9 Homo sapiens 220 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515611 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515611&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475160 461601707 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082312 CN(C)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C22H25ClN6O/c1-26(2)22(30)29-17-8-9-18(29)13-27(12-17)14-19-20(15-4-6-16(23)7-5-15)25-21-24-10-3-11-28(19)21/h3-7,10-11,17-18H,8-9,12-14H2,1-2H3 FZWGRQIFJIFVLD-UHFFFAOYSA-N 515612 US11098063, Example 119 Potassium channel subfamily K member 3 Human 5300 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515612&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 147599592 461601708 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082313 CN(C)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C22H25ClN6O/c1-26(2)22(30)29-17-8-9-18(29)13-27(12-17)14-19-20(15-4-6-16(23)7-5-15)25-21-24-10-3-11-28(19)21/h3-7,10-11,17-18H,8-9,12-14H2,1-2H3 FZWGRQIFJIFVLD-UHFFFAOYSA-N 515612 US11098063, Example 119 Potassium channel subfamily K member 9 Homo sapiens 210 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515612&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 147599592 461601708 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082314 CCOc1ccc(cc1)N(C)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C29H31ClN6O2/c1-3-38-25-13-11-22(12-14-25)33(2)29(37)36-23-9-10-24(36)18-34(17-23)19-26-27(20-5-7-21(30)8-6-20)32-28-31-15-4-16-35(26)28/h4-8,11-16,23-24H,3,9-10,17-19H2,1-2H3 WFCXWYIPOJJXQW-UHFFFAOYSA-N 515613 US11098063, Example 120 Potassium channel subfamily K member 3 Human 15000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515613&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475145 461601709 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082315 CCOc1ccc(cc1)N(C)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C29H31ClN6O2/c1-3-38-25-13-11-22(12-14-25)33(2)29(37)36-23-9-10-24(36)18-34(17-23)19-26-27(20-5-7-21(30)8-6-20)32-28-31-15-4-16-35(26)28/h4-8,11-16,23-24H,3,9-10,17-19H2,1-2H3 WFCXWYIPOJJXQW-UHFFFAOYSA-N 515613 US11098063, Example 120 Potassium channel subfamily K member 9 Homo sapiens 230 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515613&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475145 461601709 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082316 COc1cccc(c1)N(C)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C28H29ClN6O2/c1-32(21-5-3-6-24(15-21)37-2)28(36)35-22-11-12-23(35)17-33(16-22)18-25-26(19-7-9-20(29)10-8-19)31-27-30-13-4-14-34(25)27/h3-10,13-15,22-23H,11-12,16-18H2,1-2H3 TZJXTOYCNOXZQS-UHFFFAOYSA-N 515614 US11098063, Example 121 Potassium channel subfamily K member 3 Human 12000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515614&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 162678175 461601710 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082317 COc1cccc(c1)N(C)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C28H29ClN6O2/c1-32(21-5-3-6-24(15-21)37-2)28(36)35-22-11-12-23(35)17-33(16-22)18-25-26(19-7-9-20(29)10-8-19)31-27-30-13-4-14-34(25)27/h3-10,13-15,22-23H,11-12,16-18H2,1-2H3 TZJXTOYCNOXZQS-UHFFFAOYSA-N 515614 US11098063, Example 121 Potassium channel subfamily K member 9 Homo sapiens 120 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515614&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 162678175 461601710 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082318 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)N1CCSCC1 InChI=1S/C24H27ClN6OS/c25-18-4-2-17(3-5-18)22-21(30-9-1-8-26-23(30)27-22)16-28-14-19-6-7-20(15-28)31(19)24(32)29-10-12-33-13-11-29/h1-5,8-9,19-20H,6-7,10-16H2 JYVOYDUGDYFZNB-UHFFFAOYSA-N 515615 US11098063, Example 122 Potassium channel subfamily K member 3 Human 5000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515615&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148151418 461601711 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082319 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)N1CCSCC1 InChI=1S/C24H27ClN6OS/c25-18-4-2-17(3-5-18)22-21(30-9-1-8-26-23(30)27-22)16-28-14-19-6-7-20(15-28)31(19)24(32)29-10-12-33-13-11-29/h1-5,8-9,19-20H,6-7,10-16H2 JYVOYDUGDYFZNB-UHFFFAOYSA-N 515615 US11098063, Example 122 Potassium channel subfamily K member 9 Homo sapiens 120 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515615&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148151418 461601711 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082320 COC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C21H22ClN5O2/c1-29-21(28)27-16-7-8-17(27)12-25(11-16)13-18-19(14-3-5-15(22)6-4-14)24-20-23-9-2-10-26(18)20/h2-6,9-10,16-17H,7-8,11-13H2,1H3 PLJBVNXKWWICCF-UHFFFAOYSA-N 515616 US11098063, Example 123 Potassium channel subfamily K member 3 Human 14000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515616&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 148927963 461601712 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082321 COC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C21H22ClN5O2/c1-29-21(28)27-16-7-8-17(27)12-25(11-16)13-18-19(14-3-5-15(22)6-4-14)24-20-23-9-2-10-26(18)20/h2-6,9-10,16-17H,7-8,11-13H2,1H3 PLJBVNXKWWICCF-UHFFFAOYSA-N 515616 US11098063, Example 123 Potassium channel subfamily K member 9 Homo sapiens 230 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515616&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 148927963 461601712 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082322 CCOC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C22H24ClN5O2/c1-2-30-22(29)28-17-8-9-18(28)13-26(12-17)14-19-20(15-4-6-16(23)7-5-15)25-21-24-10-3-11-27(19)21/h3-7,10-11,17-18H,2,8-9,12-14H2,1H3 VMGHTJUVIWLWTF-UHFFFAOYSA-N 515617 US11098063, Example 124 Potassium channel subfamily K member 3 Human 790 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515617&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153075679 461601713 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082323 CCOC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C22H24ClN5O2/c1-2-30-22(29)28-17-8-9-18(28)13-26(12-17)14-19-20(15-4-6-16(23)7-5-15)25-21-24-10-3-11-27(19)21/h3-7,10-11,17-18H,2,8-9,12-14H2,1H3 VMGHTJUVIWLWTF-UHFFFAOYSA-N 515617 US11098063, Example 124 Potassium channel subfamily K member 9 Homo sapiens 17.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515617&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153075679 461601713 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082324 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)OC1CCCC1 InChI=1S/C25H28ClN5O2/c26-18-8-6-17(7-9-18)23-22(30-13-3-12-27-24(30)28-23)16-29-14-19-10-11-20(15-29)31(19)25(32)33-21-4-1-2-5-21/h3,6-9,12-13,19-21H,1-2,4-5,10-11,14-16H2 RBKOUIFSIQEXLK-UHFFFAOYSA-N 515618 US11098063, Example 125 Potassium channel subfamily K member 3 Human 230 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515618&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146710699 461601714 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082325 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)OC1CCCC1 InChI=1S/C25H28ClN5O2/c26-18-8-6-17(7-9-18)23-22(30-13-3-12-27-24(30)28-23)16-29-14-19-10-11-20(15-29)31(19)25(32)33-21-4-1-2-5-21/h3,6-9,12-13,19-21H,1-2,4-5,10-11,14-16H2 RBKOUIFSIQEXLK-UHFFFAOYSA-N 515618 US11098063, Example 125 Potassium channel subfamily K member 9 Homo sapiens 27.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515618&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146710699 461601714 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082326 CCCOC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C23H26ClN5O2/c1-2-12-31-23(30)29-18-8-9-19(29)14-27(13-18)15-20-21(16-4-6-17(24)7-5-16)26-22-25-10-3-11-28(20)22/h3-7,10-11,18-19H,2,8-9,12-15H2,1H3 SPKKOGBUKFOFHF-UHFFFAOYSA-N 515619 US11098063, Example 126 Potassium channel subfamily K member 3 Human 280 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515619 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515619&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475164 461601715 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082327 CCCOC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C23H26ClN5O2/c1-2-12-31-23(30)29-18-8-9-19(29)14-27(13-18)15-20-21(16-4-6-17(24)7-5-16)26-22-25-10-3-11-28(20)22/h3-7,10-11,18-19H,2,8-9,12-15H2,1H3 SPKKOGBUKFOFHF-UHFFFAOYSA-N 515619 US11098063, Example 126 Potassium channel subfamily K member 9 Homo sapiens 14.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515619 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515619&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475164 461601715 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082328 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)OC1CCCCC1 InChI=1S/C26H30ClN5O2/c27-19-9-7-18(8-10-19)24-23(31-14-4-13-28-25(31)29-24)17-30-15-20-11-12-21(16-30)32(20)26(33)34-22-5-2-1-3-6-22/h4,7-10,13-14,20-22H,1-3,5-6,11-12,15-17H2 QKCSCBVLPQPPGI-UHFFFAOYSA-N 515620 US11098063, Example 128 Potassium channel subfamily K member 3 Human 2000 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515620 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515620&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475146 461601716 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082329 Clc1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)OC1CCCCC1 InChI=1S/C26H30ClN5O2/c27-19-9-7-18(8-10-19)24-23(31-14-4-13-28-25(31)29-24)17-30-15-20-11-12-21(16-30)32(20)26(33)34-22-5-2-1-3-6-22/h4,7-10,13-14,20-22H,1-3,5-6,11-12,15-17H2 QKCSCBVLPQPPGI-UHFFFAOYSA-N 515620 US11098063, Example 128 Potassium channel subfamily K member 9 Homo sapiens 110 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515620 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515620&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475146 461601716 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082330 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)OC(C)(C)C InChI=1S/C27H35N5O2/c1-18(2)19-7-9-20(10-8-19)24-23(31-14-6-13-28-25(31)29-24)17-30-15-21-11-12-22(16-30)32(21)26(33)34-27(3,4)5/h6-10,13-14,18,21-22H,11-12,15-17H2,1-5H3 CSWJKVLBGDDCOW-UHFFFAOYSA-N 515621 US11098063, Example 130::tert-Butyl 3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]octane-8-carboxylate Potassium channel subfamily K member 3 Human 1700 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515621&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462866 461601717 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082331 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)OC(C)(C)C InChI=1S/C27H35N5O2/c1-18(2)19-7-9-20(10-8-19)24-23(31-14-6-13-28-25(31)29-24)17-30-15-21-11-12-22(16-30)32(21)26(33)34-27(3,4)5/h6-10,13-14,18,21-22H,11-12,15-17H2,1-5H3 CSWJKVLBGDDCOW-UHFFFAOYSA-N 515621 US11098063, Example 130::tert-Butyl 3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]octane-8-carboxylate Potassium channel subfamily K member 9 Homo sapiens 210 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515621&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462866 461601717 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082332 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)c1ncoc1C1CC1 InChI=1S/C29H32N6O2/c1-18(2)19-4-6-20(7-5-19)25-24(34-13-3-12-30-29(34)32-25)16-33-14-22-10-11-23(15-33)35(22)28(36)26-27(21-8-9-21)37-17-31-26/h3-7,12-13,17-18,21-23H,8-11,14-16H2,1-2H3 PALOETWSZLRKLX-UHFFFAOYSA-N 515622 (5-Cyclopropyl-1,3-oxazol-4-yl)(3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)methanone::US11098063, Example 131 Potassium channel subfamily K member 3 Human 3500 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515622&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146462853 461601718 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082333 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC(C1)N2C(=O)c1ncoc1C1CC1 InChI=1S/C29H32N6O2/c1-18(2)19-4-6-20(7-5-19)25-24(34-13-3-12-30-29(34)32-25)16-33-14-22-10-11-23(15-33)35(22)28(36)26-27(21-8-9-21)37-17-31-26/h3-7,12-13,17-18,21-23H,8-11,14-16H2,1-2H3 PALOETWSZLRKLX-UHFFFAOYSA-N 515622 (5-Cyclopropyl-1,3-oxazol-4-yl)(3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]oct-8-yl)methanone::US11098063, Example 131 Potassium channel subfamily K member 9 Homo sapiens 410 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515622&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146462853 461601718 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082334 CC(C)(C)OC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2 InChI=1S/C27H33N5O2/c1-27(2,3)34-26(33)32-21-11-12-22(32)16-30(15-21)17-23-24(29-25-28-13-4-14-31(23)25)20-9-7-19(8-10-20)18-5-6-18/h4,7-10,13-14,18,21-22H,5-6,11-12,15-17H2,1-3H3 QTEXGWJDBDZJOB-UHFFFAOYSA-N 515623 US11098063, Example 132::tert-Butyl 3-{[2-(4-cyclopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]octane-8-carboxylate Potassium channel subfamily K member 3 Human 1700 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515623&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 151644406 461601719 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082335 CC(C)(C)OC(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2 InChI=1S/C27H33N5O2/c1-27(2,3)34-26(33)32-21-11-12-22(32)16-30(15-21)17-23-24(29-25-28-13-4-14-31(23)25)20-9-7-19(8-10-20)18-5-6-18/h4,7-10,13-14,18,21-22H,5-6,11-12,15-17H2,1-3H3 QTEXGWJDBDZJOB-UHFFFAOYSA-N 515623 US11098063, Example 132::tert-Butyl 3-{[2-(4-cyclopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,8-diazabicyclo[3.2.1]octane-8-carboxylate Potassium channel subfamily K member 9 Homo sapiens 410 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515623&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 151644406 461601719 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082336 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2 InChI=1S/C29H28FN5O/c30-25-5-2-1-4-24(25)28(36)35-22-12-13-23(35)17-33(16-22)18-26-27(32-29-31-14-3-15-34(26)29)21-10-8-20(9-11-21)19-6-7-19/h1-5,8-11,14-15,19,22-23H,6-7,12-13,16-18H2 UBZOYAYWACDFMC-UHFFFAOYSA-N 515624 US11098063, Example 133 Potassium channel subfamily K member 3 Human 1600 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515624&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 152883800 461601720 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082337 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2 InChI=1S/C29H28FN5O/c30-25-5-2-1-4-24(25)28(36)35-22-12-13-23(35)17-33(16-22)18-26-27(32-29-31-14-3-15-34(26)29)21-10-8-20(9-11-21)19-6-7-19/h1-5,8-11,14-15,19,22-23H,6-7,12-13,16-18H2 UBZOYAYWACDFMC-UHFFFAOYSA-N 515624 US11098063, Example 133 Potassium channel subfamily K member 9 Homo sapiens 180 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515624&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 152883800 461601720 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082338 O=C(C1CCCC1)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2 InChI=1S/C28H33N5O/c34-27(22-4-1-2-5-22)33-23-12-13-24(33)17-31(16-23)18-25-26(30-28-29-14-3-15-32(25)28)21-10-8-20(9-11-21)19-6-7-19/h3,8-11,14-15,19,22-24H,1-2,4-7,12-13,16-18H2 OGXHGLZEGUEEHI-UHFFFAOYSA-N 515625 US11098063, Example 134 Potassium channel subfamily K member 3 Human 770 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515625 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515625&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 153475148 461601721 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082339 O=C(C1CCCC1)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2 InChI=1S/C28H33N5O/c34-27(22-4-1-2-5-22)33-23-12-13-24(33)17-31(16-23)18-25-26(30-28-29-14-3-15-32(25)28)21-10-8-20(9-11-21)19-6-7-19/h3,8-11,14-15,19,22-24H,1-2,4-7,12-13,16-18H2 OGXHGLZEGUEEHI-UHFFFAOYSA-N 515625 US11098063, Example 134 Potassium channel subfamily K member 9 Homo sapiens 97.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515625 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515625&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 153475148 461601721 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082340 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2 InChI=1S/C29H29FN6O2/c1-38-25-12-11-23(30)27(32-25)28(37)36-21-9-10-22(36)16-34(15-21)17-24-26(33-29-31-13-2-14-35(24)29)20-7-5-19(6-8-20)18-3-4-18/h2,5-8,11-14,18,21-22H,3-4,9-10,15-17H2,1H3 QOSRXQONARTPFE-UHFFFAOYSA-N 515626 US11098063, Example 135 Potassium channel subfamily K member 3 Human 420 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515626&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146695899 461601722 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082341 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2 InChI=1S/C29H29FN6O2/c1-38-25-12-11-23(30)27(32-25)28(37)36-21-9-10-22(36)16-34(15-21)17-24-26(33-29-31-13-2-14-35(24)29)20-7-5-19(6-8-20)18-3-4-18/h2,5-8,11-14,18,21-22H,3-4,9-10,15-17H2,1H3 QOSRXQONARTPFE-UHFFFAOYSA-N 515626 US11098063, Example 135 Potassium channel subfamily K member 9 Homo sapiens 34.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515626&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146695899 461601722 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082342 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2 InChI=1S/C29H29ClN6O2/c1-38-25-12-11-23(30)27(32-25)28(37)36-21-9-10-22(36)16-34(15-21)17-24-26(33-29-31-13-2-14-35(24)29)20-7-5-19(6-8-20)18-3-4-18/h2,5-8,11-14,18,21-22H,3-4,9-10,15-17H2,1H3 UGZSUYWMNNQJFA-UHFFFAOYSA-N 515627 US11098063, Example 136 Potassium channel subfamily K member 3 Human 320 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515627 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515627&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 152909952 461601723 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082343 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2 InChI=1S/C29H29ClN6O2/c1-38-25-12-11-23(30)27(32-25)28(37)36-21-9-10-22(36)16-34(15-21)17-24-26(33-29-31-13-2-14-35(24)29)20-7-5-19(6-8-20)18-3-4-18/h2,5-8,11-14,18,21-22H,3-4,9-10,15-17H2,1H3 UGZSUYWMNNQJFA-UHFFFAOYSA-N 515627 US11098063, Example 136 Potassium channel subfamily K member 9 Homo sapiens 41.0 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515627 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515627&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 152909952 461601723 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082344 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2 InChI=1S/C29H30N6O2/c1-37-26-5-2-4-24(31-26)28(36)35-22-12-13-23(35)17-33(16-22)18-25-27(32-29-30-14-3-15-34(25)29)21-10-8-20(9-11-21)19-6-7-19/h2-5,8-11,14-15,19,22-23H,6-7,12-13,16-18H2,1H3 RGJFXJOGUCOGKW-UHFFFAOYSA-N 515628 US11098063, Example 137 Potassium channel subfamily K member 3 Human 1100 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515628&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146725914 461601724 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082345 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2 InChI=1S/C29H30N6O2/c1-37-26-5-2-4-24(31-26)28(36)35-22-12-13-23(35)17-33(16-22)18-25-27(32-29-30-14-3-15-34(25)29)21-10-8-20(9-11-21)19-6-7-19/h2-5,8-11,14-15,19,22-23H,6-7,12-13,16-18H2,1H3 RGJFXJOGUCOGKW-UHFFFAOYSA-N 515628 US11098063, Example 137 Potassium channel subfamily K member 9 Homo sapiens 180 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515628&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146725914 461601724 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082346 FC(F)Oc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2 InChI=1S/C29H28F2N6O2/c30-28(31)39-25-4-1-3-23(33-25)27(38)37-21-11-12-22(37)16-35(15-21)17-24-26(34-29-32-13-2-14-36(24)29)20-9-7-19(8-10-20)18-5-6-18/h1-4,7-10,13-14,18,21-22,28H,5-6,11-12,15-17H2 RPWYFRLSHFOUQK-UHFFFAOYSA-N 515629 US11098063, Example 138 Potassium channel subfamily K member 3 Human 3200 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515629&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 152783072 461601725 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082347 FC(F)Oc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2 InChI=1S/C29H28F2N6O2/c30-28(31)39-25-4-1-3-23(33-25)27(38)37-21-11-12-22(37)16-35(15-21)17-24-26(34-29-32-13-2-14-36(24)29)20-9-7-19(8-10-20)18-5-6-18/h1-4,7-10,13-14,18,21-22,28H,5-6,11-12,15-17H2 RPWYFRLSHFOUQK-UHFFFAOYSA-N 515629 US11098063, Example 138 Potassium channel subfamily K member 9 Homo sapiens 290 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515629&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 152783072 461601725 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1082348 O=C(N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2)c1ncoc1C1CC1 InChI=1S/C29H30N6O2/c36-28(26-27(21-8-9-21)37-17-31-26)35-22-10-11-23(35)15-33(14-22)16-24-25(32-29-30-12-1-13-34(24)29)20-6-4-19(5-7-20)18-2-3-18/h1,4-7,12-13,17-18,21-23H,2-3,8-11,14-16H2 YNUWELAJINZJSQ-UHFFFAOYSA-N 515630 US11098063, Example 139 Potassium channel subfamily K member 3 Human 4500 US Patent 10.7270/Q2T43X7W aid1805867 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515630 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515630&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 149392524 461601726 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1082349 O=C(N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C1CC1)C2)c1ncoc1C1CC1 InChI=1S/C29H30N6O2/c36-28(26-27(21-8-9-21)37-17-31-26)35-22-10-11-23(35)15-33(14-22)16-24-25(32-29-30-12-1-13-34(24)29)20-6-4-19(5-7-20)18-2-3-18/h1,4-7,12-13,17-18,21-23H,2-3,8-11,14-16H2 YNUWELAJINZJSQ-UHFFFAOYSA-N 515630 US11098063, Example 139 Potassium channel subfamily K member 9 Homo sapiens 470 US Patent 10.7270/Q2T43X7W aid1805868 US11098063 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Collins, K; Lindner, N; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B 8/24/2021 2/7/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=515630 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=515630&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 149392524 461601726 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2